i-sense: EPSRC IRC in Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance
Lead Research Organisation:
University College London
Department Name: London Centre for Nanotechnology
Abstract
In 2017 the need for disruptive sensing systems to detect and limit infectious outbreaks has taken centre stage - Zika virus and Ebola add to the threat of pandemic influenza, HIV and antimicrobial resistance, for which the world remains unprepared. Infections are a global problem and our response must therefore be global in nature. The House of Commons Ebola report recognised the 'heroic' work of scientists, researchers and agencies but highlighted that 'the UK response - like the international response - was undermined by systemic delay' and 'we must take the opportunity now to ensure that the UK is not caught unprepared when the next disease emergency strikes. Lives can be lost for every day of delay.'
The i-sense2 EPSRC IRC aims to engineer a new generation of agile and globally impactful early warning sensing systems for infectious diseases and antimicrobial resistance. We are harnessing the power of mobile phones, biomedical engineering, nanotechnology, genomics and big data to detect outbreaks much earlier than ever before. Next Steps funding is pivotal to; maximising the impact of our current IRC research programme, retaining key staff and delivering a step change in our capabilities to respond to emerging infections and antimicrobial resistance. This will in-turn leverage over £10M in translational 'test bed' infrastructure, new laboratories, academic positions, studentships and industry partnerships to help ensure our sustainability as a National Centre of Excellence.
We will build on our pioneering work within our current i-sense IRC which focused on three infectious diseases - influenza, HIV and C. difficile. The step change we now propose is to engineer more 'agile' systems that are rapidly adaptable to different diseases, antimicrobial resistant strains and different countries. Recognising the need to develop new systems through an understanding of context, i-sense2 brings together multiple disciplines, Public Health England, the Africa Health Research Institute, the Royal College of General Practitioners Research Surveillance Centre, the NIHR UCLH Biomedical Research Centre, and industry to:
1. Harness deep learning of millions of symptoms reported online (e.g. social media, searches) to track outbreaks, potentially before people visit their doctors and in resource-limited settings;
2. Build smartphone connected diagnostic tests to support front-line health-workers and self-testing. We will develop low-cost biobarcode paper microfluidic tests and handheld sequencing technologies to detect the earliest biomarkers of infection and drug-resistance, and securely send results to online infectious disease clinics;
3. Create state-of-the-art visualisation tools to link patients to treatment and map disease 'hot spots' by fusing mHealth, genomic, clinical and epidemiological data;
4. Invest in the careers of our talented researchers to become future leaders;
5. Grow a National Centre of Excellence supported by a plurality of funding.
Our disease focus will expand to influenza-like-illnesses, sexually transmitted infections and resistant-bacteria, as exemplars of acute, chronic and emerging infections. We will build population-level 'test beds' in the UK and South Africa, to pilot our technologies and then bid for next stage translational funding for clinical trials and product development. Future 'IRC Next Steps Plus Awards' will explore new research directions e.g. sensing systems for Ebola and Zika virus.
i-sense2 has the potential to bring major human and economic benefits to millions of people worldwide. Patients will benefit from receiving faster access to potentially life-saving treatment. Populations will benefit from reduced disease transmission, health systems will benefit from rapid diagnostics, and patient self-management. Industry will benefit from skilled people and new commercial opportunities. Public health will benefit from more timely interventions and pandemic preparedness.
The i-sense2 EPSRC IRC aims to engineer a new generation of agile and globally impactful early warning sensing systems for infectious diseases and antimicrobial resistance. We are harnessing the power of mobile phones, biomedical engineering, nanotechnology, genomics and big data to detect outbreaks much earlier than ever before. Next Steps funding is pivotal to; maximising the impact of our current IRC research programme, retaining key staff and delivering a step change in our capabilities to respond to emerging infections and antimicrobial resistance. This will in-turn leverage over £10M in translational 'test bed' infrastructure, new laboratories, academic positions, studentships and industry partnerships to help ensure our sustainability as a National Centre of Excellence.
We will build on our pioneering work within our current i-sense IRC which focused on three infectious diseases - influenza, HIV and C. difficile. The step change we now propose is to engineer more 'agile' systems that are rapidly adaptable to different diseases, antimicrobial resistant strains and different countries. Recognising the need to develop new systems through an understanding of context, i-sense2 brings together multiple disciplines, Public Health England, the Africa Health Research Institute, the Royal College of General Practitioners Research Surveillance Centre, the NIHR UCLH Biomedical Research Centre, and industry to:
1. Harness deep learning of millions of symptoms reported online (e.g. social media, searches) to track outbreaks, potentially before people visit their doctors and in resource-limited settings;
2. Build smartphone connected diagnostic tests to support front-line health-workers and self-testing. We will develop low-cost biobarcode paper microfluidic tests and handheld sequencing technologies to detect the earliest biomarkers of infection and drug-resistance, and securely send results to online infectious disease clinics;
3. Create state-of-the-art visualisation tools to link patients to treatment and map disease 'hot spots' by fusing mHealth, genomic, clinical and epidemiological data;
4. Invest in the careers of our talented researchers to become future leaders;
5. Grow a National Centre of Excellence supported by a plurality of funding.
Our disease focus will expand to influenza-like-illnesses, sexually transmitted infections and resistant-bacteria, as exemplars of acute, chronic and emerging infections. We will build population-level 'test beds' in the UK and South Africa, to pilot our technologies and then bid for next stage translational funding for clinical trials and product development. Future 'IRC Next Steps Plus Awards' will explore new research directions e.g. sensing systems for Ebola and Zika virus.
i-sense2 has the potential to bring major human and economic benefits to millions of people worldwide. Patients will benefit from receiving faster access to potentially life-saving treatment. Populations will benefit from reduced disease transmission, health systems will benefit from rapid diagnostics, and patient self-management. Industry will benefit from skilled people and new commercial opportunities. Public health will benefit from more timely interventions and pandemic preparedness.
Planned Impact
The i-sense2 EPSRC IRC will combine cutting-edge UK research with world-leading partners to bring significant benefits to patients, the public, the NHS, Public Health England, the Africa Health Research Institute, industry, government, policy makers and regulators:
i. Patient benefit - The major beneficiaries will ultimately be patients who will benefit from rapid and reliable diagnosis of infection, and fast access to effective life-saving treatments with reduced morbidity or mortality, and improvements in quality of life.
ii. Public good - The public will benefit since early detection and diagnosis tends to curb the spread of infectious diseases, preserving the effectiveness of antimicrobials for future generations.
iii. NHS and global healthcare systems - will benefit from improved service delivery and sustainable models of community care. Widening access to testing for infectious diseases and AMR in community settings will enable more patients be tested and will increase the likelihood of identifying patients at an early acute stage where the risk of onwards transmission is high. Currently, unacceptably high numbers infections are undiagnosed or diagnosed at a late stage. Early diagnosis will enable more prompt treatment (improving health outcomes) and prevent onwards transmission. This could potentially reduce the economic cost of infectious diseases on the NHS and global healthcare system - for example, reducing hundreds of thousands of flu-related NHS GP appointments each winter, and reducing treatment costs (South Africa spends $1B per annum on HIV antiretroviral treatments). Moreover, the O'Neill Report suggests that rapid tests and better diseases surveillance, together with new antimicrobial treatments, could help to avert the estimated 10 million annual deaths related to AMR infections by 2050.
iv. Public-health benefits - include new tools to harness of millions of symptoms reported online, smartphone connected diagnostic self-tests, whole genome sequencing and data visualisation tools could transform the "active" real-time surveillance of infectious diseases and antimicrobial resistance, even for patients who do not attend clinics or from geographical regions outside the remit of conventional surveillance systems. Public Health England, the Africa Health Research Institute and global public health bodies, will benefit from the proposed early-warning sensing systems, enabling them to make more rapid, evidence-based clinical interventions and monitor the effect of these strategies in real-time
v. Commercial benefits - Beyond trained personnel, the potential commercial benefits to the UK and South Africa accrue through better population testing, prevention and care, and new employment opportunities in the emerging flourishing digital economy sector. Through our first workshop, planned at the end of year 1, we will reach out to industry and SMEs, including diagnostic test manufacturers, mobile network providers, handset manufacturers, app developers, policy makers and regulators to communicate developments in our understanding of the needs and technology developments to meet them and this will seed new collaborations, particularly with the digital, molecular and sequencing companies. The UK is at the forefront of the digital economy and 5G communication, and is well placed to grow commercial opportunities in this space. The work of i-sense2 will have commercial value and we will actively seek to exploit IP in conjunction with the partner institution Technology Transfer Offices - indeed spin outs and wealth creation for the UK will, in itself, form a major deliverable for i-sense2.
vi. Government, Policy Makers, Regulators and the media will benefit from balanced information about the facilitators and barriers to adoption and implementation of new products and practices, with the goal of responsible research innovation and lowering barriers to market entry for test developers and adoption.
i. Patient benefit - The major beneficiaries will ultimately be patients who will benefit from rapid and reliable diagnosis of infection, and fast access to effective life-saving treatments with reduced morbidity or mortality, and improvements in quality of life.
ii. Public good - The public will benefit since early detection and diagnosis tends to curb the spread of infectious diseases, preserving the effectiveness of antimicrobials for future generations.
iii. NHS and global healthcare systems - will benefit from improved service delivery and sustainable models of community care. Widening access to testing for infectious diseases and AMR in community settings will enable more patients be tested and will increase the likelihood of identifying patients at an early acute stage where the risk of onwards transmission is high. Currently, unacceptably high numbers infections are undiagnosed or diagnosed at a late stage. Early diagnosis will enable more prompt treatment (improving health outcomes) and prevent onwards transmission. This could potentially reduce the economic cost of infectious diseases on the NHS and global healthcare system - for example, reducing hundreds of thousands of flu-related NHS GP appointments each winter, and reducing treatment costs (South Africa spends $1B per annum on HIV antiretroviral treatments). Moreover, the O'Neill Report suggests that rapid tests and better diseases surveillance, together with new antimicrobial treatments, could help to avert the estimated 10 million annual deaths related to AMR infections by 2050.
iv. Public-health benefits - include new tools to harness of millions of symptoms reported online, smartphone connected diagnostic self-tests, whole genome sequencing and data visualisation tools could transform the "active" real-time surveillance of infectious diseases and antimicrobial resistance, even for patients who do not attend clinics or from geographical regions outside the remit of conventional surveillance systems. Public Health England, the Africa Health Research Institute and global public health bodies, will benefit from the proposed early-warning sensing systems, enabling them to make more rapid, evidence-based clinical interventions and monitor the effect of these strategies in real-time
v. Commercial benefits - Beyond trained personnel, the potential commercial benefits to the UK and South Africa accrue through better population testing, prevention and care, and new employment opportunities in the emerging flourishing digital economy sector. Through our first workshop, planned at the end of year 1, we will reach out to industry and SMEs, including diagnostic test manufacturers, mobile network providers, handset manufacturers, app developers, policy makers and regulators to communicate developments in our understanding of the needs and technology developments to meet them and this will seed new collaborations, particularly with the digital, molecular and sequencing companies. The UK is at the forefront of the digital economy and 5G communication, and is well placed to grow commercial opportunities in this space. The work of i-sense2 will have commercial value and we will actively seek to exploit IP in conjunction with the partner institution Technology Transfer Offices - indeed spin outs and wealth creation for the UK will, in itself, form a major deliverable for i-sense2.
vi. Government, Policy Makers, Regulators and the media will benefit from balanced information about the facilitators and barriers to adoption and implementation of new products and practices, with the goal of responsible research innovation and lowering barriers to market entry for test developers and adoption.
Organisations
- University College London (Lead Research Organisation)
- University of Surrey (Collaboration)
- OXFORD NANOPORE TECHNOLOGIES (Collaboration)
- Microsoft Research (Collaboration)
- Cambridge Life Sciences Ltd (Collaboration)
- Mologic (Collaboration)
- University College Hospital (Collaboration)
- Johns Hopkins University (Collaboration)
- O2 Telefonica Europe plc (Collaboration)
- Francis Crick Institute (Collaboration)
- Natural History Museum (Collaboration)
- Charité - University of Medicine Berlin (Collaboration)
- PUBLIC HEALTH ENGLAND (Collaboration)
- Newcastle University (Collaboration)
- RMIT University (Collaboration)
- École Polytechnique de Montréal (Collaboration)
- University of California, Los Angeles (UCLA) (Collaboration)
- Adámas Nano (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- Cuebiq (Collaboration)
- Google (Collaboration)
- NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST (Collaboration)
- BANGOR UNIVERSITY (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- Africa Health Research Institute (Collaboration)
- Royal College of General Practitioners (Collaboration)
Publications
Atchison CJ
(2023)
Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay.
in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Banner M
(2021)
A decade in review: use of data analytics within the biopharmaceutical sector.
in Current opinion in chemical engineering
Barcroft J
(2023)
OC12.06: Using online search activity for earlier detection of gynecological malignancy*
in Ultrasound in Obstetrics & Gynecology
Barriga HMG
(2022)
Coupling Lipid Nanoparticle Structure and Automated Single-Particle Composition Analysis to Design Phospholipase-Responsive Nanocarriers.
in Advanced materials (Deerfield Beach, Fla.)
Beale S
(2022)
Deprivation and exposure to public activities during the COVID-19 pandemic in England and Wales
in Journal of Epidemiology and Community Health
Bennett I
(2019)
bioRxiv
in Rapid antimicrobial sensitivity testing by single cell nanoscale optical interference
Bennett I
(2020)
Cantilever Sensors for Rapid Optical Antimicrobial Sensitivity Testing.
in ACS sensors
Brookes JC
(2023)
Thermodynamic analysis of an entropically driven, high-affinity nanobody-HIV p24 interaction.
in Biophysical journal
Title | Image created for the front cover of the journal Nature Medicine |
Description | Dr Da Huang created an African-inspired art image for the front cover of the journal Nature Medicine, to accompany the paper published by the McKendry group in partnership with the Africa Health Research Institute. the paper uses machine learning to improve quality assurance of HIV rapid tests. https://www.nature.com/articles/s41591-021-01384-9.pdf Here is the link to the artwork: https://www.nature.com/nm/volumes/27/issues/7 "Deep learning for HIV field tests Rachel McKendry, Valérian Turbé and colleagues at University College London and the Africa Health Research Institute use deep-learning algorithms to classify images of rapid human immunodeficiency virus lateral-flow tests acquired in rural South Africa. The pilot study demonstrated high levels of sensitivity and specificity relative to that of traditional visual interpretation. The cover, by Da Huang, a postdoctoral fellow in the University College London i-sense team, is influenced by African designs and illustrates the use of a mobile tablet to collect and analyze test results. This research highlights the potential of deep learning-enabled diagnostics in low-resource settings." |
Type Of Art | Artwork |
Year Produced | 2021 |
Impact | Greater visibility of our EPSRC and MRC funded research |
URL | https://www.nature.com/nm/volumes/27/issues/7 |
Description | i-sense EPSRC IRC: Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance (EP/R00529X/1) builds of the research and outcomes from the original EPSRC grant, i-sense EPSRC IRC Early-Warning Sensing Systems for Infectious Disease (EP/K031953/1). This follow on funding also includes two IRC Plus Awards, including 'A smartphone powered mRNA sequence detector' (EP/R018707/1) led by Imperial College London, and Ultra-sensitive enhanced nanosensing of antimicrobial resistance (u-Sense) (EP/R018391/1), led by Newcastle University. Since i-sense began in 2013, infectious diseases have taken centre stage - COVID-19, Ebola, Zika and AMR have joined the threats of pandemic influenza and HIV - diseases for which the world remains unprepared. i-sense brings together a remarkably strong team of researchers from five universities with the unique interdisciplinary skills sets and leadership to build the research foundations of disruptive twenty-first century digital sensing systems for infectious diseases. Highlights include: machine learning models of online symptoms adopted for national influenza and COVID-19 surveillance, IP for nanomaterials for ultrasensitive biomarker detection, smartphone applications to capture and classify rapid tests in South Africa, online patient pathways, public health dashboard in South Africa, IDRIS biomarker discovery for C. difficile, and smartphone test for Ebola serology piloted in Uganda. Carrying this work forward into i-sense Next Steps, we are building the i-sense programme into building an international Centre for Excellence. At the beginning of the pandemic, Prof McKendry led the publication of a review in Nature Medicine, on how digital technologies have been mobilised for a global public health response to COVID-19 and the associated concerns with privacy and efficacy in an evolving digital world. We also called for greater data sharing in joint perspective published in the journal Nature. Led by Prof Bill Lampos and Prof Ingemar Cox, i-sense researchers and collaborators at the UK Health Security Agency have created new machine learning models for online diseases surveillance to track prevalence of COVID-19 in the population using Google search terms (covid.cs.ucl.ac.uk/uk). These models are now being used by UKHSA for part of their community surveillance of COVID-19 and are included in Government COVID-19 statistics. Research by Dr Isabel Bennett and Jobie Budd (McKendry group, UCL), in collaboration with our partners at UKHSA and O2 (Telefonica UK), which was published in arXiv, looked at population mobility data to track the effectiveness of COVID-19 distancing measures. In October, a team led by Prof Deenan Pillay, Dr Mengdie Zhuang, and Prof Ed Manley, launched our i-sense COVID Response Evaluation Dashboard (COVID RED - covid.i-sense.org.uk), which received 25,000 views in the first 24hrs and was picked up by media including the Guardian and Sky News. The dashboard brings together disparate data from multiple sources on the Find, Test, Trace, Isolate, Support cascade in England. Our senior academics have been sharing expertise through policy advisory roles on DELVE (Dame Anne Johnson), Independent SAGE (Prof Deenan Pillay), and at the WHO (Dr Richard Pebody), while our researchers have been seconded to positions at the Joint Biosecurity Centre (Dr Isabel Bennett, Jobie Budd, Dounia Cherkaoui) and the WHO (Dr Polina Brangel). Although our focus heavily shifted to COVID-19, our core projects have continued where possible this year. At Imperial, the team led by Molly Stevens have been developing nanozymes for COVID-19 antigen detection, with funding from the IET. The McKendry team at UCL published, in Nature, our research on the use of quantum nanodiamonds in point-of-care diagnostic to significantly improve lateral flow test sensitivity - this research was picked up by over 20 news outlets. The UCL team also published their research on using lasers to rapidly detect antimicrobial resistance. This research, published in ACS Sensors, was Editors' pick and also appeared in the top 10 reads for October 2020. Our team at Newcastle University and University of Strathclyde have continued their work developing a multiplexed test capable of detecting the 'big five' carbapenemases, enzymes capable of hydrolysing carbapenems. The Newcastle team have continued work on developing a bioinformatics workflow, called Invisiogen, for identifying antimicrobial resistant genes within sequence databases. The McKendry UCL team also successfully conducted a pilot study for using a smartphone app, designed to assist end users perform and interpret HIV rapid tests, at the Africa Health Research Institute rural site to assess the performance of the new iteration of the app in deployment conditions. Finally, the users testing for the iSHOP project was completed and the team have been working on optimisation of the eSexual Health Clinic HIV self-testing and self-sampling pathways. This summary highlights some of the huge achievements within the project, but is by no means exhaustive. We have managed to support all this work through funding from EPSRC, EIT, ACE/UK HSA, Imperial, and Google, who have given us extra funding for COVID-19 specific research. |
Exploitation Route | The research has been published in open access journals, and where possible our code and datasets has been made open source. |
Sectors | Communities and Social Services/Policy Digital/Communication/Information Technologies (including Software) Healthcare Pharmaceuticals and Medical Biotechnology Other |
URL | http://www.i-sense.org.uk |
Description | Our 'Track' flagship, led by Prof Ingemar Cox, continues to work with Google and Microsoft to monitor outbreaks in populations using online search queries. These COVID-19 machine learning models are shared with the UK Health Security Agency as part of their weekly/monthly surveillance reports. The data offers an early warning signal of cases on average 17 days in advance (Lampos et al. Nature Digital Medicine, 2021). The team have also started new research using Facebook data to understand vaccine hesitancy. In our 'Test' flagship, Prof Molly Stevens led a successful £2.9M Wellcome Trust grant proposal together with Rachel McKendry and Ed Manley RO develop point-of-care tests for diagnosing cholera in stool and in water. Her team are also translating their very exciting nanozyme assay through a new venture. The i-sense teams at Newcastle University and the University of Strathclyde have been working together to develop SERS-based point of care tests for C. difficile. Building on our recent paper in Nature on spin-enhanced nanodiamond biosensing, Rachel McKendry has secured IAA funding for next stage translation. We are also delighted to see our research using machine algorithms co-created with the Africa Health Research Institute, to interpret HIV lateral flow tests published in the journal Nature Medicine. The models were made open source and shared with the Imperial REACT study for COVID-19 surveillance in the UK, involving 500,000 participants self-testing at home. Further applications are being explored in the areas of AMR and cholera, with funding from the new £5M EPSRC Digital Health Hub for AMR and the Wellcome Trust cholera surveillance programme. In 2023, the US regulator FDA has reached out to start a collaboration having seen our publication in Nature Medicine. In 2022, the McKendry team began a new UK government funded project on tracking SARS-CoV-2 in wastewater. Other research impacts include a £2.5M NIHR Programme Grant for Applied Research to Prof Claudia Estcourt and our collaboration with Prof Eleni Nastouli who leads the Advanced Pathogen Diagnostic unit at UCLH to monitor the severity of emerging COVID variants using sequencing and hospital data (Frampton et al. Lancet Infectious Diseases, 2021). The £1.4M SAFER programme with i-sense is investigating COVID-19 in NHS hospital healthcare workers. Finally, the team have very recently secured £5M funding to build a digital health hub for AMR, linking human, animal and environmental data. In December 2023, we officially started the new EPSRC Digital Health Hub for AMR, with a focus on one-health challenges bringing together currently siloed data sets spanning humans, animal and the environment led by Prof McKendry. The new Hub builds on research from i-sense and will last until November 2026, with the opportunity for further renewal. i-sense researchers are involved in three newly funded CDTs have been funded: the Engage CDT in Digital Health (UCL, Ulster); CDT in AMR (UCL) and the Quantum CDT (UCL). The i-sense team have won several key awards and prizes: Professor Molly Stevens was awarded a Damehood (2024) and the Novo Nordisk Prize (2023). Professor Rachel McKendry was awarded the Institution of Engineering and Technology (IET) AF Harvey Engineering research prize. Prof Ed Manley won the Phillip Leverhulme Prize for Geography 2022. Dr Ben Miller secured a Sir Henry Wellcome Fellowship. Prof McKendry served on the International Pandemic Preparedness Secretariat (IPPS) STEG for Diagnostics and i-sense research was invited to be featured in the report. Finally, we are exceptionally proud of our i-sense Education Alliance programme and our ECR alumni who have gone into careers in academia, industry, government and charities, including the World Health Organisation, Africa CDC, Wellcome Trust, Clinton Foundation. In 2023 we held a 10 year anniversary event bringing together over 100 people including alumni, current members and various clinical, industry and charity partners. |
First Year Of Impact | 2018 |
Sector | Digital/Communication/Information Technologies (including Software),Healthcare,Government, Democracy and Justice |
Impact Types | Societal Policy & public services |
Description | AI and healthcare (Lampos)-research briefing |
Geographic Reach | National |
Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
Impact | Artificial Intelligence (AI) can be used for tasks such as helping clinicians make decisions and monitoring patient health. AI systems could lead to improved health outcomes, but few have been trialled and evaluated in real-world clinical settings. Automation may reduce the time spent by staff on routine work, though they may require new skills to use AI systems. There are some public concerns AI could dehumanise healthcare, though others argue staff time saved through automation could then be spent caring for patients. Patient data are often used to produce and test AI systems, raising issues around data quality, accessibility and patient privacy |
URL | https://post.parliament.uk/research-briefings/post-pn-0637/ |
Description | Africa CDC (Peeling) |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Technology to detect COVID-19: Recommendation for clinical care and surveillance |
URL | https://africacdc.org/video/latest-update-on-available-technology-to-detect-covid-19-recommendation-... |
Description | British Association for Sexual Health & HIV Recommendations for STI & BBV self-sampling kits and processes |
Geographic Reach | National |
Policy Influence Type | Membership of a guideline committee |
Description | Co-Chair of Expert Advisory Group National Biosurveillance Network |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Independent SAGE report - High level recommendations, 5, page 3 (Pillay) |
Geographic Reach | National |
Policy Influence Type | Membership of a guideline committee |
Impact | A rigorous system must be implemented to embed the FTTIS data flows as much as possible within existing NHS, local authority and PHE data structures, with real time access to enable local response. It is important to provide data dashboards for the community and ensure appropriate governance and safeguards for privacy and data misuse, to ensure trust and engagement. The future application of m-health systems such as apps must be implemented within such a framework" |
URL | https://www.independentsage.org/wp-content/uploads/2020/06/IndependentSAGE-report-4.pdf |
Description | MHRA C19 Horizon Scanning (McKendry & Pillay) |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | The Horizon Scanning Programme team coordinates strategic horizon scanning work across departments, drawing on insights from experts in and outside government to challenge our thinking |
URL | https://www.gov.uk/government/groups/horizon-scanning-programme-team |
Description | Machine learning and online care pathways featured in 100 days mission implementation report |
Geographic Reach | Europe |
Policy Influence Type | Contribution to a national consultation/review |
Impact | To ensure global readiness, stakeholders must embrace and embed the enablers outlined in this report into routine healthcare systems. The report recommends a coordinated approach, involving governments, international organisations, research institutions, industry and regulatory bodies, to enhance diagnostics for both epidemic and endemic diseases. Political and financial commitment to multiplexed testing, digitally connected diagnostics, and linking diagnostics to treatment, as well as the underlying framework for diagnostics R&D to meet the goals of the 100DM, are essential to keeping populations safe |
URL | https://www.finddx.org/wp-content/uploads/2023/11/20231128_rep_ipps_making_exceptional_routine_FV_EN... |
Description | Mike Short (SAGE) |
Geographic Reach | National |
Policy Influence Type | Contribution to a national consultation/review |
Impact | Scientific Advisory Group for Emergencies (SAGE) provides scientific and technical advice to support government decision makers during emergencies. |
Description | RAE International Engineering Response (Stevens) |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Response from the engineering community on what they are doing to fight coronavirus (COVID-19). |
URL | https://www.raeng.org.uk/policy/engineering-response-covid-19-coronavirus/international-responses |
Description | SAGE (Johnson) |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Scientific Advisory Group for Emergencies (SAGE) provides scientific and technical advice to support government decision makers during emergencies. |
Description | The Independent SAGE -(Pillay) |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Independent SAGE is a group of scientists who are working together to provide independent scientific advice to the UK government and public on how to minimise deaths and support Britain's recovery from the COVID-19 crisis. |
Description | The Royal Society DELVE (Johnson) |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | DELVE group publishes evidence paper on the use of face masks in tackling Coronavirus (COVID-19) pandemic |
Description | The Royal Society RAMP (Manley) |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | RAMP is designed to; provide support for existing research groups; create new models or insights that can be used to inform the work of the Government's scientific advisors, through data science-based approaches; apply knowledge from related epidemiology domains; and triage incoming literature to ensure effective information flows. |
URL | https://royalsociety.org/topics-policy/Health%20and%20wellbeing/ramp/ |
Description | Weekly national influenza and COVID-19 surveillance report (Lampos) |
Geographic Reach | National |
Policy Influence Type | Contribution to a national consultation/review |
Impact | Public Health England (PHE) in the UK has incorporated the unsupervised models described in the referenced paper into their weekly surveillance reports about COVID-19. According to PHE, estimates from these models provided important insights into community transmission at a time where conventional surveillance had limited reach due to the fact that testing was restricted to hospitalised cases. They were analysed alongside other surveillance systems, with the broad expectation that any changes in trends would be first detected through the analysis of web searches and would then be seen at a later stage in more conventional surveillance sources. The decrease in the web search scores was interpreted as an early signal of the impact of physical distancing. The ability to quantify the lag between search engine trends and incidence trends in confirmed cases and mortality further improves the utility of this approach. |
URL | https://arxiv.org/abs/2003.08086 |
Description | World Health Organisation (Richard Peabody) |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Richard Peabody, epidemiologist leading the High Threat Pathogens Team at the WHO Regional Office for Europe. Richard previously worked at Public Health England as a collaborator on i-sense but is now on secondment to the WHO. |
URL | https://ewn.co.za/2020/08/13/european-virus-surge-due-to-relaxed-behaviour-who-expert |
Description | ACE Nanodiamonds |
Amount | £100,000 (GBP) |
Funding ID | n/a |
Organisation | UK Health Security Agency |
Sector | Public |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | BRC Funding for i-sense 2 Project III Theme |
Amount | £173,315 (GBP) |
Funding ID | BRC500/III/RMcK/101350 |
Organisation | National Institute for Health Research |
Sector | Public |
Country | United Kingdom |
Start | 09/2019 |
End | 03/2022 |
Description | Bioinspired Multiplexed Ultrasensitive Biosensing (BioSense) - ERC Advanced Grant |
Amount | € 2,496,310 (EUR) |
Organisation | European Research Council (ERC) |
Sector | Public |
Country | Belgium |
Start |
Description | COVID-19 responses funding |
Amount | £50,000 (GBP) |
Organisation | Imperial College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 03/2020 |
End | 04/2021 |
Description | COVID-19 surveillance funding |
Amount | $200,000 (USD) |
Funding ID | n/a |
Organisation | |
Sector | Private |
Country | United States |
Start | 05/2020 |
Description | CRUK EDD PMA - MagnetoCrispZyme sensor for quantification of circulating microRNA in primary care setting (Dr Luca Panariello) |
Amount | £90,987 (GBP) |
Organisation | Cancer Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2023 |
End | 08/2024 |
Description | Chair in Emerging Technologies "Multidimensional target agnostic sensing (MTAS): The next generation of biosensors-Molly Stevens |
Amount | £2,700,000 (GBP) |
Funding ID | CIET2021\94 |
Organisation | Royal Academy of Engineering |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2020 |
End | 11/2030 |
Description | EIT Health 2020 Covid-19 |
Amount | £454,972 (GBP) |
Organisation | EIT Health e.V. |
Sector | Private |
Country | Germany |
Start | 04/2020 |
End | 12/2020 |
Description | EPSRC COVID-19 funding |
Amount | £500,000 (GBP) |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2020 |
End | 03/2021 |
Description | EPSRC Digital Health Hub for Antimicrobial Resistance |
Amount | £4,195,584 (GBP) |
Funding ID | EP/X031276/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2023 |
End | 11/2026 |
Description | EPSRC Digital Health Hub for Antimicrobial Resistance |
Amount | £4,018,862 (GBP) |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2023 |
End | 11/2026 |
Description | Early Detection and Diagnosis Primer Award |
Amount | £98,866 (GBP) |
Organisation | Cancer Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2022 |
End | 01/2023 |
Description | Funding Decision, Subject to Contract, Wellcome Trust Affordable Innovations for Global Health Flagship Award |
Amount | £2,930,331 (GBP) |
Funding ID | 222836/Z/21/Z |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 06/2022 |
End | 06/2025 |
Description | Healthcare Engineering Impact Fellowship |
Amount | £500 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 09/2021 |
End | 10/2022 |
Description | Healthcare Workers: an in depth virological analysis and behavioural study during the outbreak |
Amount | £1,500,000 (GBP) |
Funding ID | MC_PC_19082 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2020 |
End | 09/2021 |
Description | IET AF Harvey Engineering Research Prize 2023 |
Amount | £350,000 (GBP) |
Funding ID | n/a |
Organisation | Institution of Engineering and Technology |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2024 |
End | 12/2026 |
Description | IMPROVING CARE FOR PEOPLE WITH SEXUALLY TRANSMITTED INFECTIONS (STIs) IN A DIGITAL NHS. |
Amount | £2,940,903 (GBP) |
Funding ID | NIHR200856 |
Organisation | National Institute for Health Research |
Sector | Public |
Country | United Kingdom |
Start | 11/2020 |
End | 11/2026 |
Description | IRC Next Steps Plus: A Smartphone Powered mRNA Sequence Detector |
Amount | £1,027,001 (GBP) |
Funding ID | EP/R018707/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2018 |
End | 09/2023 |
Description | IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-Sense). |
Amount | £1,388,114 (GBP) |
Funding ID | EP/R018391/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2018 |
End | 08/2024 |
Description | Integrated Surveillance Suite for Targeting Interventions to Cholera Outbreaks |
Amount | £2,930,331 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 06/2022 |
End | 06/2025 |
Description | Interfacing fluorescent nanodiamonds with CRISPR for ultrasensitive quantum diagnostics |
Amount | £300,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2022 |
End | 05/2026 |
Description | Label-Free Surface Enhanced Raman Analytical Toolkit for Ultra-Scale Down Manufacture of Complex Biological Proteins |
Amount | £19,940 (GBP) |
Funding ID | RGS\R1\201427 |
Organisation | The Royal Society |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2020 |
End | 03/2021 |
Description | Lecturer Helthcare Disgnostics |
Amount | £186,504 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 09/2018 |
End | 07/2021 |
Description | Malaria rapid test (I-sense Partnership Resource Fund) |
Amount | £39,500 (GBP) |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 02/2022 |
End | 09/2023 |
Description | Oxford-Berlin Research Partnership - Flexible Funding 2024 |
Amount | £5,000 (GBP) |
Organisation | University of Oxford |
Sector | Academic/University |
Country | United Kingdom |
Start |
Description | PhD Funding McKendry group |
Amount | £84,000 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 03/2022 |
End | 09/2025 |
Description | Philip Leverhulme Prize |
Amount | £100,000 (GBP) |
Organisation | The Leverhulme Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2023 |
End | 04/2025 |
Description | Plate reader for Lab at £40K |
Amount | £40,000 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 01/2024 |
End | 07/2024 |
Description | UCL Health and the Public Impact Fellowship |
Amount | £500 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 08/2022 |
End | 09/2023 |
Description | UCL Quantum Accelerator Programme |
Amount | £250,000 (GBP) |
Organisation | University College London |
Sector | Academic/University |
Country | United Kingdom |
Start | 01/2024 |
End | 07/2024 |
Description | UKRI Centre for Doctoral Training in AI-enabled healthcare systems |
Amount | £6,684,742 (GBP) |
Funding ID | EP/S021612/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2019 |
End | 09/2027 |
Description | UKRI Impact Acceleration Funding - Prototyping a rapid, ultrasensitive multiplexed biosensor for the simultaneous detection of non-coding RNA and protein for diagnosing cardiovascular disease |
Amount | £77,134 (GBP) |
Organisation | United Kingdom Research and Innovation |
Sector | Public |
Country | United Kingdom |
Start | 02/2023 |
End | 01/2024 |
Description | Ultrasensitive point of care diagnostic-Molly Stevens |
Amount | £35,000 (GBP) |
Funding ID | M945 |
Organisation | Rosetrees Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2020 |
End | 08/2021 |
Description | Virus watch NIHR |
Amount | £3,248,052 (GBP) |
Funding ID | MC_PC 19070 |
Organisation | National Institute for Health Research |
Sector | Public |
Country | United Kingdom |
Start | 03/2020 |
End | 09/2021 |
Description | Wellcome Trust - Integrated surveillance suite for targeting interventions to cholera outbreaks |
Amount | £2,930,331 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2023 |
End | 02/2026 |
Title | Affibody as direct replacement to antibodies in immunoassays |
Description | Successful use of affibodies as a less expensive and more robust alternative to antibodies in diagnostic tests. |
Type Of Material | Technology assay or reagent |
Year Produced | 2023 |
Provided To Others? | No |
Impact | Affibodies are less expensive and more robust alternative to antibodies in diagnostic tests. Currently writing a manuscript on the use of affibodies as antibody replacements in immunoassays. |
Title | Machine learning algorithms to interpret rapid tests |
Description | Machine Learning algorithms to interpret rapid tests. Models developed using library of images acquired in the field. |
Type Of Material | Technology assay or reagent |
Year Produced | 2017 |
Provided To Others? | No |
Impact | Early stage development. Publications in preparation. |
Title | Quantification of active binding sites on a nanoparticle using qPCR |
Description | Quantification of active binding sites on a nanoparticle using qPCR. Antigen of interest is bound to a short sequence of DNA. After binding to nanoparticles, and purified, the amount of bound DNA-modified antigen is quantified by qPCR. |
Type Of Material | Technology assay or reagent |
Year Produced | 2019 |
Provided To Others? | No |
Impact | Further work planned using the method for a fundamental study of the factors affecting antibody conjugation. |
Title | Smartphone app online care pathway for HIV self testing |
Description | A smartphone app online care pathway for HIV self testing, was co-created with end users in KwaZulu-Natal Natal South Africa, and successfully pilots in a rural clinic with 30 participants. |
Type Of Material | Technology assay or reagent |
Year Produced | 2019 |
Provided To Others? | No |
Impact | Publication in progress |
Title | functionalised fluorescent semiconducting polymer nanoparticles (SPNs) for biosensing |
Description | We have been devoting next generation fluorescent biosensors for both protein and nucleic acid sensing. The work that led to the adv. mat. paper in March 2023 focused on optimisation and proof-of-concept. The subsequent time has been spent on applying these particles to biosensing. These particles are brighter and more stable than conventional fluorescent probes - so offer great potential for sensors with improved sensitivity and reliability. |
Type Of Material | Technology assay or reagent |
Year Produced | 2023 |
Provided To Others? | Yes |
Impact | The chemistry behind this project can inform the design of future probes in diagnostics but also therapeutics. This work also informs the best way to functionalise particles for the desired application. |
Title | signal enhancement through the coupling to catalytic nanoparticles |
Description | Development of a platform technology for the early diagnosis of infectious diseases based on the coupling of biorecognition agents to secondary catalytic nanoparticles. Use of peroxidase-mimicking nanozymes for bioassay signal enhancement and thus improvement of the sensitivity of diagnostic assays. |
Type Of Material | Technology assay or reagent |
Year Produced | 2023 |
Provided To Others? | No |
Impact | Application of this signal enhancement strategy can be leveraged for the development and engineering of future diagnostic devices to incorporate nanozymes and thus improve bioassay performance. |
Title | Flu detector |
Description | Machine learning model to nowcast influenza activity in the UK. The database include Twitter, unique Google API and symptoms reported to the RCGP. |
Type Of Material | Computer model/algorithm |
Provided To Others? | No |
Impact | Zou, B., Lampos, V., Gorton, R. & Cox, I.J. 'On Infectious Intestinal Disease Surveillance using Social Media Content' Proceedings of the 6th International Conference on Digital Health (2016); PDF. Preotiuc-Pietro, D., Lampos, V. & Aletras, N. 'An analysis of the user occupational class through Twitter content' Proceedings of the 53rd annual meeting of the Association for Computational Linguistics, ACL (2015); PDF Lampos, V., Miller, A.C., Crossan, S. & Stefansen, C. 'Advances in nowcasting influenza-like influenza rates using search query logs' Scientific Reports 5, 12760 (2015); DOI: 10.1038/srep12760. Preotiuc-Pietro D., Volkova S., Lampos V., Bachrach Y. & Aletras N. 'Studying User Income through Language, Behaviour and Affect in Social Media' PLoS ONE 10(9): e0138717; DOI: 10.1371/journal.pone.0138717. Lampos, V., Yom-Tov, E., Pebody, R. & Cox, I.J. 'Assessing the impact of a health intervention via user-generated Internet content' Data Mining and Knowledge Discovery 5, 1434-1457 (2015); DOI: 10.1007/s10618-015-0427-9. Yom-Tov, E., Cox, I.J., Lampos, V. & Hayward, A.C. 'Estimating the secondary attack rate and serial interval of influenza-like illnesses using social media' Influenza and other respiratory viruses 9, 191-199 (2015); DOI: 10.1111/irv.12321. Zhang, C., Zhou, S., Miller, J.C., Cox, I.J. & Chain, B.M. 'Optimizing Hybrid Spreading in Metapopulations' Scientific Reports 5, 9924 (2015); DOI: 10.1038/srep09924. Yom-Tov, E., Borsa, D., Hayward, A.C., McKendry, R.A. & Cox, I.J. 'Automatic Identification of Web-Based Risk Markers for Health Events' Journal of Medical Internet Research 17(1):e29, (2015); DOI: 10.2196/jmir.4082 Yom-Tov, E., Borsa, D., Cox, I.J. & McKendry, R.A. 'Detecting Disease Outbreaks in Mass Gatherings Using Internet Data' J. Med. Internet Res. 16(6):e154, (2014); DOI: 10.2196/jmir.3156. Hayward, A.C. et al, 'Comparitive Community burden and severity of seasonal and pandemic influenza: results of Flu watch cohort study' The Lancet Respiratory Medicine 2, 445-454 (2014); DOI: 10.1016/S2213-2600(14)70034-7. |
URL | http://fludetector.cs.ucl.ac.uk |
Title | IDRIS |
Description | Biomarker discovery software platform- Version 1.0 of the IDRIS Web interface has been completed, together with a dataset generated from a recent NCBI Genbank snapshot. The system will soon be hosted on dedicated hardware, allowing for expansion for the increasing number of new genome sequence. Development work has started on v2.0. |
Type Of Material | Computer model/algorithm |
Provided To Others? | No |
Impact | By harnessing the revolution in genomic sequencing we will continue to develop cloud computing-based bioinformatics work-flows to identify novel markers or groups of biomarkers - pathogen-specific "finger prints".Currently we have established workflows to detect unique "tokens" (short peptide sequences) for any group of organisms of interest. |
Title | ILI_Rates_US_Weekly.csv |
Description | National level weekly ILI rates for the US |
Type Of Material | Database/Collection of data |
Year Produced | 2023 |
Provided To Others? | Yes |
URL | https://figshare.com/articles/dataset/ILI_Rates_US_Weekly_csv/23296109 |
Title | Library of rapid HIV test images under development in partnership with AHRI |
Description | A library of photographs of HIV tests has been acquired in rural KwaZulu Natal in South Africa. Images acquired by m-africa and i-sense researchers and AHRI health workers. |
Type Of Material | Database/Collection of data |
Year Produced | 2017 |
Provided To Others? | No |
Impact | The library images are being used to support early stage machine learning models to interpret HIV test results. |
Title | Raw data files for research into detection of the big five carbapenemase genes |
Description | The data represents the raw data files associated with our publication article entitled - Multiplex detection of the big five carbapenemase genes using solid-phase recombinase polymerase amplification |
Type Of Material | Database/Collection of data |
Year Produced | 2023 |
Provided To Others? | Yes |
URL | https://data.ncl.ac.uk/articles/dataset/Raw_data_files_for_research_into_detection_of_the_big_five_c... |
Title | Research Data Supporting "Coupling Lipid Nanoparticle Structure and Automated Single Particle Composition Analysis to Design Phospholipase Responsive Nanocarriers" |
Description | Raw research data supporting Barriga, Pence, et al. 2022, Advanced Materials. https://doi.org/10.1002/adma.202200839 |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
URL | https://zenodo.org/record/6414798 |
Title | Selected_Queries.csv |
Description | Search queries ranked by composite score for different influenza seasons in the US. Search query frequency data are provided by Google under a license agreement that prohibits sharing them publicly. However, access to this data can be provided to research teams by Google - using this data is not a unique privilege for the authors of this paper. You can contact the Google Trends team at trends-api-support@google.com to obtain access to this data. |
Type Of Material | Database/Collection of data |
Year Produced | 2023 |
Provided To Others? | Yes |
URL | https://figshare.com/articles/dataset/Selected_Queries_csv/23296103 |
Description | Adamas Nanotechnologies |
Organisation | Adámas Nano |
Country | United States |
Sector | Private |
PI Contribution | Stakeholder engagement |
Collaborator Contribution | Knowledge transfer from research to industry |
Impact | N/a |
Start Year | 2022 |
Description | Africa Health Research Institute |
Organisation | Africa Health Research Institute |
Country | South Africa |
Sector | Charity/Non Profit |
PI Contribution | current close working relationship between AHRI and UCL and represents a key strategic initiative to extend collaborations in education, research, business and healthcare, within the global health sector. AHRI will provide the necessary resources to facilitate this project in order to accomplish its objectives. As AHRI Chief Scientific Officer I am highly supportive of the goals outlined in this proposal and the opportunity to enable the highest calibre science to be brought to bear on a population with the most significant burden of need. |
Collaborator Contribution | The ability to link clinical and laboratory-based studies with social science, health systems research and population health data maximizes the potential to undertake biological, causal and interventional research at AHRI. The laboratory base in Durban is currently expanding, in collaboration with other partners, to facilitate human and pathogen genomics underpinned by high-level bioinformatics, biomarker screening, and pathogenesis research. Data, including extensive Department of Health patient records, is singly managed within a health informatics data repository. This maximises the opportunity for understanding the health of the surveillance population, and in conducting intervention studies to mitigate the adverse impact of the HIV/TB epidemics through improved treatment and care of affected individuals. It is this setting which provides a major opportunity to explore the best approach to visualisation of such complex data with impact of using innovative technology to support HIV prevention in South Africa. Basing this research within our setting ensures a rapid route to impact, as well as policy change. |
Impact | On-going |
Start Year | 2014 |
Description | Andrew Azman John Hopkins University on cholera diagnostics |
Organisation | Johns Hopkins University |
Country | United States |
Sector | Academic/University |
PI Contribution | PhD student Elliott Rogers has been working with Johns Hopkins on development of the rig for image analysis |
Collaborator Contribution | Image analysis for disease detection with researcher |
Impact | Early stage research |
Start Year | 2023 |
Description | Bangor University are partners on the ACE EMHP Wastewater project with the UK Health Security Agency |
Organisation | Bangor University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Rachel McKendry's research team develop multiplexed, sensitive rapid assays to detect the low levels of biomarkers in wastewater |
Collaborator Contribution | Bangor University provide the samples for the Postpandemic sensors: Harnessing isothermal amplification and quantum nanodiamonds for wastewater epidemiology project |
Impact | The outcomes of this work will be two assays and one proof-of-concept: 1. Lateral flow assay 2. Proof-of-concept ultra-sensitive nanodiamond lateral flow assay (to reduce amplification time) 3. Proof of concept data using WBE samples |
Start Year | 2021 |
Description | C. difficile diagnostic test evaluation grant application |
Organisation | Newcastle upon Tyne Hospitals NHS Foundation Trust |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The SERS lateral flow C. difficile test developed in this grant has matured to the point of a diagnostic test evaluation in the NHS. The Newcastle and Strathclyde research team have collaborated with a consultant microbiologist, Dr John Perry, in the Newcastle Upon Tyne Foundation NHS trust to submit a follow grant application to the MRC Development Pathway Gap Fund in order to do a preliminary diagnostic test evaluation on real patient samples. |
Collaborator Contribution | The SERS lateral flow C. difficile test developed in this grant has matured to the point of a diagnostic test evaluation in the NHS. The Newcastle and Strathclyde research team have collaborated with a consultant microbiologist, Dr John Perry, in the Newcastle Upon Tyne Foundation NHS trust to submit a follow grant application to the MRC Development Pathway Gap Fund in order to do a preliminary diagnostic test evaluation on real patient samples. |
Impact | Grant application in review |
Start Year | 2024 |
Description | CRISPR microfluidics chips - Dr Michael Kaminski |
Organisation | Charité - University of Medicine Berlin |
Country | Germany |
Sector | Academic/University |
PI Contribution | design and optimisation of a spatially separated microfluidic CRISPR chip |
Collaborator Contribution | design and synthesis of orthogonal CRISPR targets and guides to demonstrate the multiplexing capability of the assay |
Impact | Ongoing multi-disciplinary collaboration involving molecular diagnostics, biochemistry and device engineering |
Start Year | 2023 |
Description | Cambridge Life Sciences |
Organisation | Cambridge Life Sciences Ltd |
Country | United Kingdom |
Sector | Private |
PI Contribution | Collaborated with Newcastle University on Biosensors and immunosensor projects |
Collaborator Contribution | Technical Director will act in an advisory capacity on senior design and manufacture and also conducting market research for relevant applications including technology being developed into key commercial target areas |
Impact | None as of yet |
Start Year | 2017 |
Description | Collaboration with Imperial College |
Organisation | Imperial College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Prof. Stevens is currently Professor of Biomedical Materials and Regenerative Medicine at Imperial College London in the Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering. She has excellent support on the Departmental level that provides access to state-of-the-art equipment and instrumentation, such as the Harvey Flowers Characterisation suite. Her research programme is housed within 500m2 of space on most of the 6th floor within the Institute of Biomedical Engineering, which includes dedicated space for synthetic as well as biological studies. She also has a room dedicated to Raman spectroscopic studies, along with access to facilities and core support such as histological analyses, FACS, cleanroom facilities and confocal microscopy. In addition, she has a satellite group in the Francis Crick Institute, a £700M newly constructed world-class biomedical institute located in the heart of central London. |
Collaborator Contribution | Imperial are completing the construction of the Michael Uren Biomedical Engineering Research Hub, a 13-storey building comprising state-of-the-art laboratory and office facilities for the next generation of biomedical engineering research. i-sense2 activities will be offered half a floor within the Hub, where research towards the developing biosensing technologies can be executed. This is equivalent to an in-kind building infrastructure contribution of £5M. Imperial can confirm that the Department of Bioengineering will prioritise the recruitment of an external candidate to a lectureship in biosensing/diagnostics. This is an in-kind contribution of £400,000 over 5 years, including start-up funds. Imperial's Department of Bioengineering will underwrite a minimum of four 3.5-year PhD studentships in the area of nanomaterial-based research for diagnostics (value £300,000). |
Impact | he nanomaterials-based designs from the Stevens programme developed in this consortium are high impact. Further investment would greatly support their validation in the field and contribute towards their optimal use as biosensors at the point-of-care. Publications from the programme based on these technologies have been published in Science, ACS Sensors and Nanoscale, while several others are being completed. Their demonstrated capability of a point-of-care technology in Uganda in 2015 is extraordinary and shows the potential for these approaches as viable tools for the biosensing and healthcare communities. Overall the "i-sense" consortium performed exceptionally well and is prepared to continue to research innovative biosensing and mobile network-based approaches to combating infectious diseases. Imperial College fully supports this i-sense2 proposal as the next step to continue pushing the forefront of the field to deliver technologies with real impact. |
Start Year | 2013 |
Description | David Leon, London School for Hygiene and Tropical Medicine |
Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Looked at Web search data to investigate whether the introduction of minimum unit pricing (MUP) in Scotland on 1 May 2018 was reflected in changes in the likelihood of alcohol-related queries submitted to an internet search engine, and in particular whether there was any evidence of increased interest in purchasing of alcohol from outside Scotland. |
Collaborator Contribution | See above |
Impact | Publication: What on-line searches tell us about public interest and potential impact on behaviour in response to minimum unit pricing of alcohol in Scotland DA Leon, E Yom-Tov, AM Johnson, M Petticrew, E Williamson, V Lampos, ... Journal of Addiction 116 (8), 2008-2015 |
Start Year | 2019 |
Description | Development of a CRISPR diagnostic for urogenital schistosomiasis |
Organisation | Natural History Museum |
Country | United Kingdom |
Sector | Public |
PI Contribution | Dounia Cherkaoui (PhD student in McKendry group) is developing a CRISPR-based diagnostic test for urogenital schistosomiasis. |
Collaborator Contribution | Our partners, Dr Bonnie Webster, is providing expertise on schistosomiasis and clinical samples. |
Impact | no output yet. A publication is being written. |
Start Year | 2020 |
Description | Francis Crick Institute |
Organisation | Francis Crick Institute |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The Crick Institute has worked with this IRC since it began in 2013 . Since then we have added i-sense Flu meeting at the Institute of Materials in London and also at the i-sense seminar series. Also provided strategic advice. |
Collaborator Contribution | The Crick Institute is also interested to compare how their Google models compare to impact assessments that we measure at the World Influenza Centre e.g. from winter deaths and flu cases in ICU and in wards and would be happy to support Rachel in any new types of assessment. The value of this in-kind contribution - strategic advice, samples, to host students and data - which will not be charged to i-sense2, is estimated to be £5k. |
Impact | Crick closely believe the vision for the IRC to create a UK platform supporting the effective translation from lab to clinic of potentially game-changing early sensing systems for infections, with broad applicability to non-communicable diseases. |
Start Year | 2017 |
Description | Google UK |
Organisation | |
Department | Google UK |
Country | United Kingdom |
Sector | Private |
PI Contribution | i-sense work on data collection both at an individual level through novel nanomaterials for diagnosis, and at a national level though nowcasting via aggregate data analysis - including data contributed by Google. At the end of the pathway, they conduct user research into the end-user needs of early warning systems. |
Collaborator Contribution | ? Provided access to aggregate, anonymised search trend data. i-Sense have used this data to build predictive model. This level of access to data isn't generally available, even for research purposes. Our specific collaboration with i-Sense allows us to explore approaches for future, wider, access. While this is not a commercial arrangement, commercial access to aggregate data with similar predictive properties, for example content posted on Twitter, would have cost in the region of £50,000. Google UK intend to maintain this level of access, and include any data quality improvements we develop. ? Hosted a researcher, Bill Lampos, from i-Sense within Google as part of our Visiting Faculty programme. This programme allows external researchers to continue their research within Google for the duration of a placement, during which time they benefit from access to Google's technology, and consultation with Google's engineers and research scientists. The are also paid a salary - often around £40,000. Should project goals align, we would consider repeating such a placement in future. ? Advisory capacity provided as an active member of i-Sense's advisory board, and by speaking at a number of the events organised by the group. |
Impact | Twitter data is fed into PHE flu reports for the UK |
Start Year | 2017 |
Description | Imperial REACT study |
Organisation | Imperial College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The i-sense team collaborated with the Imperial REACT study who lead one of the largest COVID-19 surveillance programmes involving self-testing at home. Machine learning algorithms developed by the McKendry group (i-sense and m-Africa programme) were shared with the Imperial REACT study and have been used to analyse over 500,000 COVID lateral flow tests. |
Collaborator Contribution | https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/ Launched in April 2020, the REACT programme is one of the world's largest and most comprehensive coronavirus monitoring studies. The programme is led by a world-class team of researchers at Imperial College London in partnership with Ipsos MORI, and commissioned by the Department of Health and Social Care. The programme uses home testing to track the progress of England's epidemic, offering a high-resolution snapshot of how the virus and spreading and who is most at risk. REACT data are regularly reported to Government to inform and shape decision-making. The programme forms part of Pillar 4 of the government's COVID-19 testing strategy, to conduct UK-wide surveillance testing to learn more about the spread of the disease and inform the development of new tests and treatments. It adds to the data already being collected by UK Health Security Agency and the Office for National Statistics. |
Impact | Publication in progress Highly multidisciplinary |
Start Year | 2021 |
Description | Imperial Stevens group and Ecole Polytechnique de Montreal Gervais' group collaboration |
Organisation | École Polytechnique de Montréal |
Country | Canada |
Sector | Academic/University |
PI Contribution | provided expertise on nanoparticles based diagnostic assays and clinically relevant biomarkers |
Collaborator Contribution | provided expertise on design of microfluidic devices applied as immunoassays |
Impact | Multidisciplinary collaboration involving microengineering, bioengineering, biosensing and nanoscience. |
Start Year | 2021 |
Description | Imperial Stevens group and RMIT Yarovsky group collaboration |
Organisation | RMIT University |
Country | Australia |
Sector | Academic/University |
PI Contribution | The Stevens group contributes expertise on nanoparticle synthesis and nanoparticle based diagnostic assays (NLISA, LFIA). |
Collaborator Contribution | The Yarovsky group contributes expertise in molecular dynamics simulations to understand protein fouling in LFIAs. |
Impact | This is an interdisciplinary collaboration involving molecular dynamics simulations and nanomaterial based diagnostics. |
Start Year | 2022 |
Description | Microsoft Research Israel |
Organisation | Microsoft Research |
Country | Global |
Sector | Private |
PI Contribution | Worked together to develop surveillance tools for COVID-19. 1. Software/algorithms to qualitatively measure the prevalence of COVID-19 nationally 2. Software/algorithms to detect sub-national regional anomalies in COVID-19 case counts. |
Collaborator Contribution | See above |
Impact | Data was shared with PHE during the COVID-19 pandemic |
Start Year | 2020 |
Description | Mologic |
Organisation | Mologic |
Country | United Kingdom |
Sector | Private |
PI Contribution | To research and identify advancements of diagnosing and online pathways for sexually transmitted diseases |
Collaborator Contribution | Materials (substrates, lateral flow based components) |
Impact | None as of yet |
Start Year | 2017 |
Description | Newcastle University |
Organisation | Newcastle University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Newcastle are collaborators led by Neil Keegan |
Collaborator Contribution | i) Newcastle University has created a cohort of Newcastle University Research Fellowships (NURFs). These are five year, tenure-track positions designed to convert promising early career independent scientists into full academic members, with more experienced academics providing support and guidance to aid our NURFs in establishing thriving research groups, writing successful grants and producing high quality publications. They are given a generous start-up package and we are prepared to support them financially for up to 5 years until they can bring in their own funding. They are set clear publication and grant funding targets for these 5 years and if these are met (externally validated) they will subsequently be given an open-ended appointment at the end of this term. Recruitment is dependent on evidence of existing 'star quality' respective to their peer group. As part of the NURF process, a salary line within their host research Institute has to be identified before the position can be advertised. For i-sense follow-on, a suitable salary line has been identified and agreed with the Director of the Institute of Cellular Medicine (ICM). This provides the opportunity to recruit a NURF within ICM in the area of molecular diagnostic technologies (value ~£300,000). The NURF would join the group as an independent researcher but would add to the critical mass of the group. ii) As part of capacity building in this area we can confirm that the University has recruited an external candidate to a lectureship in molecular diagnostic technologies who will start in Newcastle on 1st August 2017. iii) The Institute of Cellular Medicine will underwrite a 3 year PhD studentship in the area of Diagnostic and Therapeutic Technologies (value £70,000). |
Impact | The team has developed a bioinformatics pipeline (IDRIS) which, has targeted the rapid, specific detection of Clostridium difficile as well as, excitingly, providing proof of concept for the detection of other specific bacterial organisms, both Gram positive and Gram negative. Patent applications have been lodged for IDRIS system itself and antibodies against aF protein which is specific to all strains of C. difficile and which does not occur in closely related organisms. Publications are being held to be submitted as soon as a priority date for the patent applications has been secured. A spin-out company is a real possibility and the team are working closely with our Research and Enterprise team on an independent market analysis. The detection and diagnosis of specific bacterial infections facilitated by IDRIS is a major breakthrough in terms of rapid diagnostics but the next vital step in dealing with, or controlling, infection is effective treatment with antibiotics. Therefore the Newcastle team will investigate the adaptation of the IDRIS approach to target rapid systems for identification of antimicrobial resistance. We are committed to building upon our success by supporting the growth of Diagnostic Technologies for Healthcare and by retaining and further developing key research staff, - thus providing an impetus to i-sense which will contribute significantly towards sustainability. |
Start Year | 2013 |
Description | Oxford Nanopore Technologies |
Organisation | Oxford Nanopore Technologies |
Country | United Kingdom |
Sector | Private |
PI Contribution | Collaboration opportunities are around upstream protocol development and engineering of sample presentation, in the areas of TB and HIV, feasibility studies in collaboration with AHRI plus downstream analysis ie using machine learning techniques which are being developed by i-sense researchers. |
Collaborator Contribution | MinION Enhanced Starter Pack, a fully supported start to nanopore sequencing Potentially presentations at bi-annual meetings. |
Impact | MinION starter pack |
Start Year | 2017 |
Description | Partnership with Cuebiq |
Organisation | Cuebiq |
Country | United States |
Sector | Private |
PI Contribution | Testing and feedback on data service platform. |
Collaborator Contribution | Provision of access to data for mobility analyses, as well as expertise on methods underlying data. |
Impact | Ross, S., Breckenridge, G., Zhuang, M. and Manley, E., 2021. Household visitation during the COVID-19 pandemic. Scientific reports, 11(1), pp.1-11. |
Start Year | 2020 |
Description | Public Health England |
Organisation | Public Health England |
Country | United Kingdom |
Sector | Public |
PI Contribution | PHE have worked closely with i-sense over the past five years, with a series of successful outcomes including the development of Google and Twitter tools that are intended to strengthen national surveillance of influenza through early warning; the use of social media to evaluate the community impact of a new paediatric influenza vaccination programme and Exploratory projects to determine the feasibility of self-testing through a web-enrolled cohort and the cost-effectiveness of near patient testing for managing seasonal and pandemic influenza. Through fur the r collaboration including joint studentships between PHE and the other IRC partners, i-sense2 intends to extend these approaches to predictive modelling for influenza and to other emerging infections. |
Collaborator Contribution | PHE would envisage at this stage that the contribution in-kind from PHE, in in terms of my own time for consultancy and attendance of bi-monthly progress meetings, and that of the lab would be estimated as contribution in-kind over the period of the i-sense follow-on project. |
Impact | PHE have worked closely with i-sense over the past five years, with a series of successful outcomes including the development of Google and Twitter tools that are intended to strengthen national surveillance of influenza through early warning |
Start Year | 2013 |
Description | Royal College of General Practitioners |
Organisation | Royal College of General Practitioners |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | i-Sense has investigated how the network of primary care data can be supplemented with syndromic data derived from Twitter and Google search logs. This approach, using RCGP RSC data for machine learning purpose, was evaluated by PHE, and is very likely to be incorporated into PHE's weekly influenza reports for the 2017/18 flu season. RCGP RSC data has also been used in a very innovative method to assess the effectiveness of a PHE child influenza vaccination pilot. Once again RCGP data was used to train models based on Twitter, Google, and Microsoft Bing data to estimate influenza prevalence in both pilot and control regions. This work was reported in a paper entitled "Assessing the Impact of a Health Intervention via User-generated Internet Content", published in Data Mining and Knowledge Discovery, Volume 29, Issue 5, Page 1434-1457, 2015. |
Collaborator Contribution | The Royal College of General Practitioners (RCGP) has a access to regularly updated primary care data based on our network of 200 Research and Surveillance Centre (RSC) practices, encompassing approximately 1.5m patient datasets all pseudoannonymised and downloaded on a weekly basis. This data is used for a variety of approved public health and research purposes, including estimation of the prevalence of influenza on the general population for Public Health England (PHE). Raw data are kept on the RCG RSC data and analytics hub at University of Surrey. This network complies with NHS requirements for a secure network and personal data does not leave this network. |
Impact | All data provision will follow RCGP RSC data approval processes to ensure secure network protocols are met. |
Start Year | 2017 |
Description | Telefonica |
Organisation | O2 Telefonica Europe plc |
Country | United Kingdom |
Sector | Private |
PI Contribution | A strong research team which does research and field testing. There are now opportunities to scale up the testing and healthcare prevention to a systems level |
Collaborator Contribution | Advisory and Steering group representation on digital technologies & industrial links to key players |
Impact | Strategic guidance on the Advisory Board |
Start Year | 2016 |
Description | University College Hospital, London |
Organisation | University College Hospital |
Country | United Kingdom |
Sector | Hospitals |
PI Contribution | Collaboration between i-sense and the Advanced Pathogen Diagnostics Unit at UCLH. Collaboration involved sharing of sample, clinical data for sequencing and dashboards |
Collaborator Contribution | Provided samples for clinical validation of new diagnostic tests Provided clinical data for analysis |
Impact | TBC |
Start Year | 2015 |
Description | University of California, LA |
Organisation | University of California, Los Angeles (UCLA) |
Country | United States |
Sector | Academic/University |
PI Contribution | UCLA have been collaborating with i-sense for approximately 2 years now, and have already hosted two graduate students from Prof. McKendry's lab to transfer some of our lab's expertise on mobile phone based sensing and diagnostics technologies toward infectious disease surveillance. Prior to this, UCLA also had an opportunity to visit UCL's lab in 2014 and presented at the i-sense EPSRC IRC New Frontiers in Digital Technologies for Influenza workshop that she organized at the Institute of Materials in London. |
Collaborator Contribution | As an i-sense2 Project Partner UCLA will contribute to the design and prototyping of novel smartphone connected photonic diagnostic tests developed in partnership with i-sense and hosting students. In turn, I look forward to the opportunity to work together on pilot studies of these devices in the UK and South Africa, write joint papers and new grant proposals together. |
Impact | Collaborations on the use of computational imaging, sensing and diagnostics technologies for mobile health, infectious disease screening and related applications. |
Start Year | 2014 |
Description | University of Surrey |
Organisation | University of Surrey |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Surrey is a research collaborator on the i-sense 2 |
Collaborator Contribution | Also, developed test-beds for health care with industrial partners Huawei, Os, BT/EE, 3, BBC, McLaren & NHS |
Impact | Surrey will be recruiting a Professor and Lecturer specifically into the e-health space and this equates to an investment of some £200,000 as part of our research support. For priming our research theme activities we have also committed £100,000 per annum to our Innovation for Health programme. |
Start Year | 2013 |
Title | Nanozyme-catalysed detection of nucleic acids |
Description | The present invention relates to systems and methods of detecting nucleic acids using a combination of a Cas-based reaction with a catalytic nanoparticles. |
IP Reference | 2110729.7 |
Protection | Patent application published |
Year Protection Granted | 2021 |
Licensed | No |
Impact | Patent pending. |
Title | Signal enhancement through the coupling to secondary catalytic nanoparticles |
Description | Signal enhancement through the coupling to secondary catalytic nanoparticles |
IP Reference | 2402663.5 |
Protection | Patent / Patent application |
Year Protection Granted | |
Licensed | No |
Impact | n/a |
Title | Detection limit fitting tool |
Description | Maltab application for fitting dilution series data to calculate detection limits and associated stats. |
Type Of Technology | Webtool/Application |
Year Produced | 2022 |
Open Source License? | Yes |
Impact | Linked to publication: https://www.sciencedirect.com/science/article/abs/pii/S0956566322001737 |
URL | https://github.com/bensmiller/detection-limit-fitting |
Title | Smartphone application based online care pathway for HIV self testing |
Description | Smartphone application based online care pathway for HIV self testing, co-creaed with AHRI. The app was in English and isi Zulu, with audiovisual guide to HIV self testing and a timer to ensure the test is read at the correct time. The app was successfully piloted on 30 patients in a clinic. |
Type Of Technology | Webtool/Application |
Year Produced | 2019 |
Impact | publication underway |
Description | 17th Int.Joint Conf. on e-Business and telecommunications (Lampos) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Analysing Digital Footprints to Infer the Health of Populations and Individuals |
Year(s) Of Engagement Activity | 2020 |
Description | 25th International Conference on Miniaturized Systems for Chemistry & Life Sciences (Sara Carvalho) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | On October 10 - 14, the leading researcher from ISSP UL's Laboratory of Prototyping of Electronic and Photonic Devices, Dr.sc.ing. Roberts Rimša represented CAMART2 and project funded by the Latvian Council of Science Microfluidic field flow fractionation for high throughput extra-cellular vesicle separation in a poster presentation and paper "Towards extracellular vesicle-friendly microfluidic devices" at the 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences. The research is carried out in collaboration with the Latvian Biomedical Research and Study Centre (BMC). |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.camart2.com/en/events/participation-in-25th-international-conference-on-miniaturized-sys... |
Description | 31st Anniversary World Congress on Biosensors |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | A talk on multivalent DNA biosensor for infectious disease diagnostics with single-molecule control by Dr Da Huang |
Year(s) Of Engagement Activity | 2021 |
URL | https://bios-elsevier.web.indrina.com/sign-in |
Description | 7th Analytical Biosciences Early Career Researchers Meeting (Thomas) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Nanoparticle Empowered Diagnostics |
Year(s) Of Engagement Activity | 2020 |
Description | A presentation at Scix 2021 at USA. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Talk presented was titled "SERS detection of bacterial biomarkers using paper based nanosensor". The talk was well received and generated follow questions by participants interested in the technology and approach. |
Year(s) Of Engagement Activity | 2021 |
URL | https://scixconference.org/ |
Description | Adam Creamer - Semiconducting polymer nanoparticles for cancer imaging |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | PDRA Adam Creamer presented the talk "Semiconducting polymer nanoparticles for cancer imaging" at International Conference on the Science and Technology of Synthetic Metals 2022 in Glasgow, 17 July 2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Annual i-sense meeting |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Carl Emil Aae Eskildsen of Imperial College London gave an oral presentation on Point-of_Need Application: Miniaturised Raman device detecting Antimicrobial Resistance. 50-100 academics, postgraduates and research council staff. |
Year(s) Of Engagement Activity | 2022 |
Description | Apolitical-Lampos |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Search results are helping tackle COVID19_now we should use them to develop policies |
Year(s) Of Engagement Activity | 2020 |
Description | Applied Physical Sciences Conference, Cambridge March 2022 (Invited talk) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Invited to engage with the academic community on diagnostics |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.infectiousdisease.cam.ac.uk/external-workshops |
Description | BBC (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Could search engines predict the spread of coronavirus? |
Year(s) Of Engagement Activity | 2020 |
Description | BBC News, BBC Radio 4's, Times Radio Drive', BBC Radio 4's 'PM' BBC Radio 4's 'Today Programme' ,ITV News |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | UK case rises are 'concerning' |
Year(s) Of Engagement Activity | 2020 |
Description | BBC News- Pillay |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Shared facilities at swimming pools pose risk of Coronavirus transmission |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.bbc.co.uk/news/explainers-53349989 |
Description | BBC Radio 4 |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Could the new Covid-19 tests help prepare for a second wave? |
Year(s) Of Engagement Activity | 2020 |
Description | BBC Radio 4 -More: BMJ, The Guardian (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Academics express concern about antibody test rollout |
Year(s) Of Engagement Activity | 2020 |
Description | BBC Radio London (Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Does the technology for rapid Covid-19 testing exist? |
Year(s) Of Engagement Activity | 2020 |
Description | BHF Centre of Research Excellence Symposium (Stevens) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Biosensing platforms |
Year(s) Of Engagement Activity | 2020 |
Description | BIOENG2022 - Molly Stevens - Bioengineering approaches for early disease detection and therapeutics |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the talk "Bioengineering approaches for early disease detection and therapeutics" at BIOENG2022 on 3-5 July 2022 to an international audience of scientists and students. |
Year(s) Of Engagement Activity | 2022 |
Description | BMJ (Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Room for improvement: first NHS Test and Trace figures released |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.bmj.com/content/369/bmj.m2404 |
Description | BMJ/UCL News -Andrew Hayward (2021) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Analysis: We have entered a dangerous new phase of the pandemic. Read: BMJ, More: UCL News |
Year(s) Of Engagement Activity | 2021 |
Description | Bioengineering for global health webinar (BioGloW)-2022 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Talk on communications biology |
Year(s) Of Engagement Activity | 2022 |
URL | https://register.gotowebinar.com/register/6643707073914298383 |
Description | Biosensors 2020, 30th Anniversary World Congress on Biosensors (Huang) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Multivalent DNA biosensor for infectious disease diagnostics with single-molecule control |
Year(s) Of Engagement Activity | 2020 |
Description | Biosensors 2021 (Cherkaoui, Miller and Huang) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Multivalent DNA biosensor for infectious disease diagnostics with single-molecule control -Dr Da Huang Spin-enhanced fluorescent nanodiamond biosensing for ultrasensitive lateral flow diagnostics -Dr Ben Miller Towards a rapid and dual smartphone-read diagnostic test for Zaire and Sudan ebola viruses-Dounia Cherkaoui |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.elsevier.com/events/conferences/world-congress-on-biosensors |
Description | Biosensors 2023 -Chris Johnson and Neil Keegan |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Academics attended Biosensors 2023 is a premier event and the largest in the field celebrates its 33rd anniversary with another excellent line-up of twelve plenary and invited keynote speakers, high-quality contributed oral talks, two summer schools, large poster sessions and an exhibition. As with previous events in the series it provides unrivalled networking opportunities and a compete update on international biosensors research and commercialisation. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.rsc.org/events/detail/75178/biosensors-2023 |
Description | Bloomberg-Peeling |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | How to Test for Coronavirus_ Prospect of a 10-Minute Diagnosis |
Year(s) Of Engagement Activity | 2020 |
Description | Bradford Telegraph & Express and Star (Pillay & Pagel) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Data gaps make it impossible to assess test and trace system, researchers say |
Year(s) Of Engagement Activity | 2020 |
Description | British Association for Sexual Health & HIV (BASHH) Annual Conference 2020-Lloyd, Blandford & Estcourt |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Feasibility and acceptability of receiving reactive HIV self-test results at home within an online clinical pathway |
Year(s) Of Engagement Activity | 2020 |
Description | British Association for Sexual Health & HIV (BASHH) Annual Conference 2020-Lloyd, Blandford & Estcourt |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Acceptability of i-reader mobile camera technology in an online HIV self-testing pathway |
Year(s) Of Engagement Activity | 2020 |
Description | CNET (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Google searches could illuminate the shadowy spread of the coronavirus |
Year(s) Of Engagement Activity | 2020 |
Description | COVID for Christmas? Analysing patterns of Christmas mobility in the UK (Ross & Breckenbridge) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | In response to public curiosity, and as a guide for health policymakers, this article provides a timely overview of actual mobility patterns observed over the 2020 Christmas period in the UK and their COVID-19 impacts. Using smartphone mobility data, it attempts to address: 1.How mobile was the UK population over the Christmas period (23rd-27th Dec 2020)? 2.Were these mobility patterns aligned with the UK government's revised Christmas policy? 3.Did mobility patterns have a detectable effect on UK COVID-19 growth rates? |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.cdrc.ac.uk/covid-for-christmas-analysing-patterns-of-christmas-mobility-in-the-uk/ |
Description | CT3N - Molly Stevens - Designing bioengineering approaches for biosensing and therapeutics |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the keynote lecture "Designing bioengineering approaches for biosensing and therapeutics" at the Centre for Targeted Therapeutics and Translational Nanomedicine, Philadelphia, USA, 7 Dec 2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Channel 4 news -Andew Hayward (2020) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Will a tiered Covid-19 lockdown work? |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.channel4.com/news/current-covid-restrictions-only-tackle-part-of-problem-says-prof-andre... |
Description | Chris Johnson presented at the i-sense annual meeting London |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Chris Johnson presented at the i-sense annual meeting London - Isothermal amplification mediated detection of the "big 5" carbapenemase genes |
Year(s) Of Engagement Activity | 2022 |
Description | Covid-19 rates continue to climb-Radio 4 |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Listen: BBC Radio 4's 'PM' (from 31 mins 56 secs), More: BBC Radio 2's 'Jo Whiley Show' (from 30 mins 24 secs), Read: Independent |
Year(s) Of Engagement Activity | 2021 |
Description | Designing nanomaterials for ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary talk presented by Prof Molly Stevens to an international audience Biosensors 2021, 31st anniversary world congress on biosensors, 26-29 July, |
Year(s) Of Engagement Activity | 2021 |
Description | Diagnostics for Low- and Middle-Income Countries (LMICs) Conference-27th & 28th March |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Undergraduate students |
Results and Impact | Conference in Oxford which linked academics from Lower and Middle Income countries to discuss challenges and potential ways forward. A follow up conference will happen in 2024. The inaugural meeting of an annual global health conference hosted by Reuben College took place on 27 and 28 March on the topic of Diagnostics for low- and middle-income countries (LMICs). Fifty delegates, including a dozen graduate students from Reuben, UCL and Imperial, took part in a highly participatory meeting, with a focus on discussions and learning from one another. |
Year(s) Of Engagement Activity | 2023 |
URL | https://reuben.ox.ac.uk/event/diagnostics-low-and-middle-income-countries-conference |
Description | Digital Connectivity and Covid-19 Response Workshop (McKendry) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | The Importance of Digital Technology for effective Covid-19 Response - Showcasing countries examples, initiatives and success stories |
Year(s) Of Engagement Activity | 2020 |
Description | Digital Footprints conference presentation |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation of research at digital footprints conference, led to engagement in form of questions and discussion. |
Year(s) Of Engagement Activity | 2023 |
Description | Discussion on use of mobile technologies to capture diagnostic data with WHO Global Laboratories Alliance for Diagnosis of High Threat Pathogens (GLAD-HD) |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | Deenan Pillay - Discussion on use of mobile technologies to capture diagnostic data with WHO Global Laboratories Alliance for Diagnosis of High Threat Pathogens (GLAD-HD) |
Year(s) Of Engagement Activity | 2019 |
Description | Duncan Graham presented @ the Nanoinnovation conferences September 2022 in Italy |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Duncan Graham presented the talk - Point of Use SERS for Biomolecular Detection - at the Nanoinnovation conference in Italy September 2022 |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.nanoinnovation2022.eu/home/index.php?Itemid= |
Description | ECR Festival (Zhaung) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Dashboards |
Year(s) Of Engagement Activity | 2020 |
Description | ESB Conference - Molly Stevens - Designing and translating new biomaterials for heal the body and detect diseases earlier |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof. Molly Stevens presented the talk "Designing and translating new biomaterials for heal the body and detect diseases earlier" at the European Society for Biomaterials Conference ESB to an international audience of scientists and research studnets in Bordeaux, France, 5-7 Sep 2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Economic Times (India)-Bennett |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Scientists develop faster way of detecting antibiotic resistance in bacteria |
Year(s) Of Engagement Activity | 2020 |
Description | Emerging Technologies and Medical Devices Event |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Supporting Medical Devices Clinical Research within the UK |
Year(s) Of Engagement Activity | 2020 |
Description | Evening standard- Andrew Hayward (2020) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Timely circuit-break lockdown would have prevented need for longer-term restrictions |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dailymail.co.uk/news/article-8840293/Herd-immunity-approach-coping-coronavirus-dangerous... |
Description | Express Pharma (Bennett) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Scientists develop faster way of detecting antibiotic resistance in bacteria |
Year(s) Of Engagement Activity | 2020 |
Description | Grand Challenges - Designing materials to transform therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the virtual talk "Designing materials to transform therapeutics and ultrasensitive biosensing" at the Grand Challenges in Materials Science : Innovators in Bioengineering webinar, 26 April 2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Great Exhibition Road Festival |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | More than 1000 people were introduced to the basics of light-matter interactions, and how this can play a pivotal role in the development of new diagnostic technologies |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.greatexhibitionroadfestival.co.uk/ |
Description | Great Exhibition Road Festival - Stevens Group - 2022 |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | The Stevens Group hosted a stall at the Great Exhibition Road Festival featuring an activity for children and general audiences to explain how lateral flow tests work using Velcro and balls. |
Year(s) Of Engagement Activity | 2022 |
Description | Great Exhibition Road Festival 2023 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | o Event: Great Exhibition Road Festival o Date and Place: London, 17-18 June 2023 o Type of presentation: Public Engagement activity (games and discussion) o Title: CRISPR/Cas ball pit and Rainbow to diagnose Illnesses |
Year(s) Of Engagement Activity | 2023 |
Description | Great Exhibition Roadshow (Science Festival) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | The Great Exhibition Roadshow is a weekend of free events for all ages celebrating the inspirational power of awe and wonder in science and the arts. This year, the roadshow had an estimated 38,000 attendees. The Stevens Group at i-sense led a fun, interactive stand on lateral flow tests. Christy, i-sense PhD student who led the project said, "It was great to have a platform to interact with members of the public and fuel their excitement for science. Our simple Velcro ball game helped to explain how lateral flow tests really work, and it was rewarding to equip visitors with knowledge about how lateral flow tests can be used to diagnose a range of diseases". |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.i-sense.org.uk/news/public-engagement-annual-overview |
Description | Guardian (Hayward) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Explaining the rule of six |
Year(s) Of Engagement Activity | 2020 |
Description | Guardian (Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Loosening restrictions could trigger a second wave of Covid-19 |
Year(s) Of Engagement Activity | 2020 |
Description | Guardian (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Beijing restricts travel to halt new coronavirus outbreak |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.theguardian.com/world/2020/jun/16/beijing-coronavirus-outbreak-travel-restricted-china-s... |
Description | Guardian (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | UK virologists criticise handling of Covid-19 testing contracts |
Year(s) Of Engagement Activity | 2020 |
Description | Guardian (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Experts share doubts about coronavirus 90-minute tests |
Year(s) Of Engagement Activity | 2020 |
Description | Guardian-Anne Johnson |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | What can Britain learn about containing Covid-19 from countries that got it right_ |
Year(s) Of Engagement Activity | 2020 |
Description | HDRUK Annual Scientific Conference session on 'Behavioural data in action - the role of self-reported and other data' |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Policymakers/politicians |
Results and Impact | Presented in workshop session with Susan Michie, Stephen Reicher, and John Edmunds on the use of different data for pandemic response. |
Year(s) Of Engagement Activity | 2021 |
Description | Healthcare Engineering @ UCL ECR Symposium |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Postgraduate students |
Results and Impact | Presentation at Early Career Researcher Symposium on Healthcare Engineering at UCL 2nd place oral presentation prize |
Year(s) Of Engagement Activity | 2021 |
Description | HuffPost (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | How Your Google Search Data Is Used To Track Coronavirus |
Year(s) Of Engagement Activity | 2020 |
Description | IOM3 Webinar (Miller) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Nano4Health -'Advances in Combatting COVID19' |
Year(s) Of Engagement Activity | 2020 |
Description | IUPESM WC2022 - Molly Stevens - Bioengineering Approaches to Heal the Body and Detect Diseases Earlier |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented a virtual talk at the IUPESM WC 2022 (Singapore) on 16/June/2022 entitled "Bioengineering Approaches to Heal the Body and Detect Diseases Earlier" |
Year(s) Of Engagement Activity | 2022 |
Description | Important to maintain trust in Covid-19 vaccinations (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Watch: Channel 4 News |
Year(s) Of Engagement Activity | 2021 |
Description | Independent (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Is Boris Johnson's father undermining coronavirus measures with Greek visit? |
Year(s) Of Engagement Activity | 2020 |
Description | India News Republic (Bennett) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Laser-based method for detecting antibiotic-resistant strains invented by British scientists |
Year(s) Of Engagement Activity | 2020 |
Description | Int Conf Multifunctional, Hybrid and nanomaterials - Molly Stevens - Engineering bio-inspired materials for therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the plenary talk "Engineering bio-inspired materials for therapeutics and ultrasensitive biosensing" at the International Conference on Multifunctional, Hybrid and Nanomaterials in Genoa, Italy on 20/October/2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Invited talk to FDA |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Policymakers/politicians |
Results and Impact | Invited talk to FDA |
Year(s) Of Engagement Activity | 2023 |
Description | Keynote presentation at workshop hosted by University of Liverpool and Korea Research Institute for Human Settlements (KRIHS) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Provided a keynote speech at a workshop on 'Supporting Post Pandemic Recovery and Resilience Through New Forms of Data', co-hosted by the University of Liverpool and Korea Research Institute for Human Settlements (KRIHS). The talk was entitled Movement Data for Analysing Behaviour during the Pandemic, and prompted numerous questions from students and staff. |
Year(s) Of Engagement Activity | 2022 |
Description | Keynote speaker - Royal Society of Chemistry Analytical Biosciences Group AGM |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Postgraduate students |
Results and Impact | i-sense PhD student John-Paul Ayrton was a keynote speaker at Royal Society of Chemistry Analytical Biosciences Group AGM held at King's College London. Open to all, in person & online. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.rsc.org/events/detail/75011/rsc-analytical-biosciences-group-annual-general-meeting |
Description | Keynote speech at SpaceTimeLab 10th Anniversary workshop |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Gave a keynote speech on a variety of work, led to discussions and questions following. |
Year(s) Of Engagement Activity | 2023 |
Description | Lancet Big Data Summit 2022 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Talk: Going viral: harnessing data science, sensors and data visualisation for the early detection of infectious diseases |
Year(s) Of Engagement Activity | 2022 |
URL | https://thelancetsummit.com/big-data-ai/bio-McKendry.asp |
Description | Lancet Summit Talk |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Professor Rachel McKendry provided a virtual presentation at Lancet Summit on Big Data and AI in pandemic preparedness. Talk was open to all, online and was followed by questions and discussion. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.thelancetsummit.com/big-data-ai/default.asp?utm_medium=SORG&utm_source=TW&dgcid=STMJ_164... |
Description | Lancet Summit: Big Data and AI in Pandemic Preparedness 2022 (Invited talks) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Invited to engage with the academic community on diagnostics |
Year(s) Of Engagement Activity | 2022 |
URL | http://thelancetsummit.com/big-data-ai/?CMX_ID=&SIS_ID=&dgcid=STMJ_158683_EVNT_E |
Description | Lustrum: Improving partner notification with accelerated partner therapy -YOU TUBE |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | You tube video to explain research findings from research programme |
Year(s) Of Engagement Activity | 2021 |
Description | MRS Fall - Molly Stevens - Designing bioelectronic materials for regenerative medicine and biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented an inivted talk at MRS Fall Symposium SB03 Materials and Designs for 3D bioelectronic Interfaces "Designing bioelectronic materials for regenerative medicine and biosensing", 29/Nov/2022, Boston USA |
Year(s) Of Engagement Activity | 2022 |
Description | MRS Spring Meeting Honolulu (Invited talk and Chair) 2022 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Undergraduate students |
Results and Impact | Invited to engage with the academic community on diagnostics |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.mrs.org/meetings-events/spring-meetings-exhibits/2022-mrs-spring-meeting |
Description | MSB 2020 (Stevens) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Designing Materials for Ultrasensitive Biosensing |
Year(s) Of Engagement Activity | 2020 |
Description | Mail Online, Guardian, Wales Online, Mirror, Listen: BBC Radio 4's 'Today Programme' |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | 500,000 people a day will show Covid-19 symptoms this winter |
Year(s) Of Engagement Activity | 2020 |
Description | Mail online (2020) Deenan Pillay |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Experts criticise herd immunity in letter |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dailymail.co.uk/news/article-8840293/Herd-immunity-approach-coping-coronavirus-dangerous... |
Description | Mail online (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Are the 90 minute tests for Covid-19 a game changer? |
Year(s) Of Engagement Activity | 2020 |
Description | Mail online-Andrew Hayward (2021) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Lockdown has 'split the population in two' |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.mailonsunday.co.uk/news/article-9150747/Boris-urged-seize-UK-curbing-Covid-surge-DOUBLIN... |
Description | Media article in an online magazine in response to a publications on paper based bacterial detection using SERS |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | media article on our scientific output in the Analytical Scientist. The 2021 publication in the RSC Analyst journal on detecting bacteria using paper and SERS generated media interest and we gave interviews to the Analytical Scientist to create further awareness of our work across the many publics. |
Year(s) Of Engagement Activity | 2021 |
URL | https://theanalyticalscientist.com/fields-applications/c-difficile-but-not-impossible |
Description | Medicinteknikdagarna - Molly Stevens - Designing materials for therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the plenary talk "Designing materials for therapeutics and ultrasensitive biosensing" at Medicinteknikdagarna in Lulea, Sweden, 6/October/2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Miken Institute MEA Summit (Stevens) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Data and Disease: Detecting and Solving Global Health Threats |
Year(s) Of Engagement Activity | 2020 |
Description | Multifunctional Nanoparticles for Biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | A research talk presented to an international audience "Multifunctional Nanoparticles for Biosensing" |
Year(s) Of Engagement Activity | 2021 |
Description | Nanotech2019, TechConnect World Innovation Conference and Expo (Huang) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Multivalent DNA Biochips for Investigations of Cancer Cell Spreading with Nanoscale Spatial Resolution and Single-Molecule Control |
Year(s) Of Engagement Activity | 2019 |
Description | Nature (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Real-time flu tracking |
Year(s) Of Engagement Activity | 2020 |
Description | Neil Keegan and Chris Johnson presented at the Conference 5th International Caparica Conference in Antibiotic Resistance 2022 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Chris Johnson and Neil Keegan presented the talk - Isothermal amplification mediated detection of the "big 5" carbapenemase genes - in Portugal Spain September 2022 at the 5th International Caparica Conference in Antibiotic Resistance 2022 |
Year(s) Of Engagement Activity | 2022 |
URL | https://ic2ar2022.bioscopegroup.org/type-of-contributions/index.html |
Description | New Scientist Live - Science Festival Stand |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | In October 2022, a team from the McKendry group attended New Scientist Live (London) as part of the Quantum City stand, alongside collaborators from various institutions such as University of Sheffield, Birmingham and Nottingham respectively. The interactive i-sense stand showcased the quantum capabilities of nanodiamonds for highly sensitive viral detection (based on Miller at al., 2020, as published in Nature). During the weekend there were almost 3,000 counted visitors to the Quantum City stall. In addition, video content was produced during the day which was widely disseminated on website/social media channels, engaging a wider audience including general public and researchers. The day also promoted collaboration and i-sense was invited to the planning of future events. |
Year(s) Of Engagement Activity | 2022 |
URL | https://twitter.com/isenseIRC/status/1579419223318986752 |
Description | New York Times -Lampos |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Google Searches Can Help Us Find Emerging Covid-19 Outbreaks |
Year(s) Of Engagement Activity | 2020 |
Description | New hybrid materials for ultrasensitive biosensing and regenerative medicine |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary talk by Prof Molly Stevens IUPAC-World Polymer Congress MACRO 2020+ , Jeju, Korea and Virtual, 18 May 2021 |
Year(s) Of Engagement Activity | 2021 |
Description | ONS Data Science Campus Virtual Knowledge Exchange |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | Presentation at ONS DSC Virtual Knowledge Exchange on applications of mobile phone data in mobility |
Year(s) Of Engagement Activity | 2023 |
Description | OneZero (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Google Searches Reveal Covid-19 Hot Spots Before Governments Do |
Year(s) Of Engagement Activity | 2020 |
Description | OneZero (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Your Google Searches Could Shape the Response to the Next Pandemic |
Year(s) Of Engagement Activity | 2020 |
Description | Oral presentation: Harnessing Spin-Enhanced Nanodiamonds for Early Disease Diagnosis given by Benjamin Miller at the MRS Spring Meeting in Honolulu, USA, 9-11 May 2022. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Invited oral presentation given on behalf of Rachel McKendry |
Year(s) Of Engagement Activity | 2022 |
Description | Oral presentation: Nanodiamond Diagnostics: Improving Sensitivity by Spin Manipulation given by Benjamin Miller at the MRS Spring Meeting in Honolulu, USA, 9-11 May 2022. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Research presentation at international confernece in NM05 (nanodiamonds for bio and other sensing applications) |
Year(s) Of Engagement Activity | 2022 |
Description | Outlook India (Bennett) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Scientists develop faster way of detecting antibiotic resistance in bacteria |
Year(s) Of Engagement Activity | 2020 |
Description | Panellist at US Geospatial Intelligence Foundation GEOINTegration Summit |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Panel held to discuss COVID-19 and geospatial analysis, involved discussion with panellists and attendees |
Year(s) Of Engagement Activity | 2020 |
Description | Physics world - (Miller & McKendry) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Spin-enhanced nanodiamonds could improve disease diagnosis |
Year(s) Of Engagement Activity | 2021 |
URL | https://physicsworld.com/a/spin-enhanced-nanodiamonds-could-improve-disease-diagnosis/ |
Description | Presented a talk at the virtual RSC conference "Materials tackling infectious disease" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Presented a talk "Development of DNA aptamers against the Mycobacterium tuberculosis biomarker ManLAM " at the virtual RSC conference "Materials tackling infectious disease" The talk generated questions and discussions around the need for rapid diagnostics in Low to middle income countries. It also had follow up conversations subsequently. A follow up PhD studentship proposal was successfully submitted from these discussions. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.rsc.org/events/detail/47905/materials-tackling-infectious-disease-a-networking-workshop |
Description | Presented a talk to Molecular Mechanisms of Life theme Newcastle University |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | Presented a talk "Development of a multiplex isothermal amplification assay for point of care detection of the "big 5" carbapenemase genes " at Molecular Mechanisms of Life, seminar series, Newcastle University. The talk generated internal discussions of other application areas for the technology |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.ncl.ac.uk/medical-sciences/research/research-themes/biomolecules/ |
Description | Press release and media coverage 'Household visitation during the COVID-19 pandemic' |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Contributed to a press release and took part in a press briefing organised by Nature Springer around the publication of 'Household visitation during the COVID-19 pandemic'. The work was covered and quotes used in over 200 media outlets including The Metro (print), the Telegraph, the Wall Street Journal, the Daily Mail, Yahoo News, MSN News, and by the Press Association. It was also covered in articles in the Conversation, the Guardian, and Geography Directions. The paper was also covered widely on Twitter. The Almetrics on the paper put it 'in the top 5% of all research outputs scored'. |
Year(s) Of Engagement Activity | 2021,2022 |
Description | Prof Molly Stevens presented an invited talk at the MRS Spring Meeting in Honolulu, USA, 9-11 May 2022. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Molly Stevens presented an invited talk - Designing biomaterials for disease detection and exploration - at the MRS Spring Meeting in Honolulu, USA, 9-11 May 2022. |
Year(s) Of Engagement Activity | 2022 |
Description | Q&A: SARS-CoV-2 Diagnostics (Miller) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Central Saint Martins (University of the Arts London) |
Year(s) Of Engagement Activity | 2020 |
Description | RME 2023 Chris Johnson and Neil Keegan |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Postgraduate students |
Results and Impact | RME2023 - the 15th conference in the Rapid Methods Europe series dedicated to innovations and breakthroughs in rapid analysis & diagnostics across the agri-food, plant science, environment (water), healthcare (human, animal), and forensic science sectors - has come to an end.The common theme of this year's event was 'HOW CAN WE LEARN FROM EACH OTHER?' The conference focused on the technology rather than the sector, aiming to bring together scientists with different expertise with the possibility of cross-fertilizing each other and developing new views and applications. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.rapidmethods.eu/ |
Description | Rachel McKendry Plenary Lecture at RCOG World Congress_June 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary Lecture at RCOG World Congress |
Year(s) Of Engagement Activity | 2019 |
Description | Rachel McKendry_Talk at 2019 NMC STI Workshop on Nanomechanical Sensors_Lausanne_June 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In the 2019 edition we want to focus our workshop in two of the most promising fields: quantum and bio-sensing. We are putting together an exciting program with 8 keynote speakers and more than 10 invited speakers of the top international tier. We expect to attract around 150-200 people from all over the world. Very importantly, in our even we will put in contact two apparently very separate communities as are quantum and bio-sensing communities. The main objective during the workshop will be to explore the synergies between them. The School of Engineering of EPFL supports the organization of scientific workshops on the EPFL campus on topics of heightened interest at the forefront of research. These workshops attract highly visible and internationally recognizable speakers. |
Year(s) Of Engagement Activity | 2019 |
URL | https://memento.epfl.ch/event/nmc-2019-sti-workshop-on-nanomechanical-sensors/ |
Description | Rachel McKendry_Talk at Future of Individualized Medicine_San Diego_March 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In 2019, the newly renamed Future of Individualized Medicine (formerly Future of Genomic Medicine) conference will expand to include additional perspectives on how to tailor medicine to the individual. Individualized medicine takes into account a person's genes-and genomics will remain a core topic for exploration and discussion-but it also considers the full spectrum of a person's uniqueness from their biologic, physiologic, anatomic, lifestyle and environmental information. The Future of Individualized Medicine conference will thus incorporate perspectives from the emerging fields of digital medicine, artificial intelligence and machine learning, behavioral science and others. This is truly a multidisciplinary forum designed to accelerate the transformation of medicine. |
Year(s) Of Engagement Activity | 2008,2019 |
URL | https://www.scripps.edu/science-and-medicine/translational-institute/about/events/foim/ |
Description | Radio 4 'the briefing room'-Anne Johnson |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | 'Backward' contact tracing will give more data on coronavirus |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.bbc.co.uk/sounds/play/m000ncq0 |
Description | Radio 4 Today-Johnson |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Covid-19 infections increasing faster than expected, experts say |
Year(s) Of Engagement Activity | 2020 |
Description | Radio 5 (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | What can we expect from pubs as lockdown eases? |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.bbc.co.uk/sounds/play/m000k9p7 |
Description | Rapid Methods Europe Conference Poster Madhura Bharati |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Poster presented to Academics/Students/Industry |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.rapidmethods.eu/ |
Description | Read: i News, More: UCL News (Hayward) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | New study into Covid-19 transmission and immunity launched |
Year(s) Of Engagement Activity | 2020 |
Description | Royal Society of Chemistry |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Professor McKendry led the programme which featured keynote speakers covering detection and diagnosis, vaccines and therapies, and tackling transmission - materials in the environment, followed by structured networking sessions to build new connections and explore how materials innovations can be translated to clinical application. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.rsc.org/ |
Description | SAGE Publishing (Lampos) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | In a pandemic, what use is Google? |
Year(s) Of Engagement Activity | 2020 |
Description | STI & HIV World Congress 2021 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Prof Claudia Estcourt was a plenary speaker on Digital sexual health |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.stihiv2021.org/ |
Description | School Visit (Norwood) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Anna Byrne (i-sense Communications Manager) attended Norwood School (London) as part of International Women's Day on 8th March 2023. The visit involved providing 3 x 30 min sessions to 3 different classes of 14/15 year olds, reaching around 110 students in total. The school has many students from underprivileged, diverse backgrounds including refugees from various countries. We discussed an overview of i-sense related research and varied career paths. Did interactive activities (quiz & microbe drawing competition) relevant to antimicrobial resistance. Held a Q&A - answering all the students' questions and creating discussion. The student and teacher feedback forms were very positive. |
Year(s) Of Engagement Activity | 2023 |
Description | Sensors in Medicine 2021 (Invited talk) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Invited to talk and engage with the academic community on diagnostics |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.rsc.org/events/detail/48124/sensors-in-medicine-2021 |
Description | Sensors in Medicine 2022 Conference |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Prof. McKendry provided a talk at the 2022 Sensors in Medicine Conference |
Year(s) Of Engagement Activity | 2022 |
Description | Sensors in Medicine in 2024 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Working across and beyond traditional scientific disciplines -the i-sense EPSRC IRC 10 year anniversary lecture |
Year(s) Of Engagement Activity | 2024 |
URL | https://medilinksouthwest.com/events/sensors-in-medicine-2024 |
Description | Sky News Live Updates (i-sense team) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Scientists warn of 'significant gaps' in England's Test and Trace data |
Year(s) Of Engagement Activity | 2020 |
Description | Soho Radio (Miller) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | GLOBAL HEALTH GLOBAL BEATS |
Year(s) Of Engagement Activity | 2020 |
Description | Stevens talk - 2020 Milken Institute MEA Summit - Abu Dhabi |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | A research talk presented to an international audience |
Year(s) Of Engagement Activity | 2020 |
Description | Stevens talk - Emerging technologies and medical devices event, London |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | A research talk presented to an international audience |
Year(s) Of Engagement Activity | 2020 |
Description | Stevens talk - World Economic Forum, Davos -2020 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | A research talk presented to an international audience "Biosensors and the future of diagnostics" |
Year(s) Of Engagement Activity | 2020 |
Description | Sunday Times (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Did China find clues to the coronavirus in 2013? |
Year(s) Of Engagement Activity | 2020 |
Description | Swedish Chemical Society 2022 - Molly Stevens - Designing nanomaterials for therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented a plenary talk entitled "Designing nanomaterials for therapeutics and ultrasensitive biosensing" at the Swedish Chemical Society Meeting on the 20th June 2022. |
Year(s) Of Engagement Activity | 2022 |
Description | Swiss Nano-Convention 2020 (McKendry) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Swiss Nanoscience Institute |
Year(s) Of Engagement Activity | 2020 |
Description | Swiss NanoConvention 2021 (invited talk) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Undergraduate students |
Results and Impact | Invited to engage with the academic community on diagnostics |
Year(s) Of Engagement Activity | 2021 |
URL | https://2021.swissnanoconvention.ch/ |
Description | TNS (Bennett) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Scientists develop faster way of detecting antibiotic resistance in bacteria |
Year(s) Of Engagement Activity | 2020 |
Description | Tabasom Haghighi - A nanozyme-based immunoassay for sensitive detection of malaria transmission |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | PhD student Tabasom Haghighi presented the poster "A nanozyme-based immunoassay for sensitive detection of malaria transmission" in the i-sense annual meeting on the 15/Dec/2022 |
Year(s) Of Engagement Activity | 2022 |
Description | Talk at 2019 Chief Scientific Officer's Annual Conference_March 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | Talk at 2019 Chief Scientific Officer's Annual Conference |
Year(s) Of Engagement Activity | 2019 |
Description | Talk at the Government Data Science Festival |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | We ran a workshop at the Government Data Science Festival on 'How the ESRC Consumer Data Research Centre (CDRC) is making use of consumer data for public good'. It was attended by around 30 civil servants from across government departments, and led to numerous questions and discussions of research findings. |
Year(s) Of Engagement Activity | 2022 |
Description | Talk for Nature conference (Virtual Age of Medicine) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | This Nature Conference focused on recent advances in the development, application and implementation of strategies to deliver health care and health education via remote technologies - connecting individuals and health professionals, bringing care to low-resource settings, and ensuring equal access for all. Prof. McKendry provided a talk on Digital Diagnostics to a large virtual audience, which sparked questions and discussion. The link to attend was shared on social media platforms such as the i-sense Twitter page, in order to maximise reach. |
Year(s) Of Engagement Activity | 2022 |
URL | https://conferences.nature.com/event/0b87c6fb-30cf-495a-9da0-88b2a9bf0681/summary |
Description | Telegraph (Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Prepare now for a winter COVID-19 peak, say UCL experts |
Year(s) Of Engagement Activity | 2020 |
Description | Telegraph (Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Prepare now for a winter COVID-19 peak, say UCL experts |
Year(s) Of Engagement Activity | 2020 |
Description | The Conversation (Zhuang & Manley) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | England's contact-tracing system needs better data handling to beat COVID-19 |
Year(s) Of Engagement Activity | 2020 |
Description | The Guardian -Anne Johnson (2021) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Plan now to minimise Covid-19 risk next winter -Read: Guardian, Listen: BBC World Service's 'Newshour' (from 18 mins 55 secs) |
Year(s) Of Engagement Activity | 2021 |
Description | UCL News (Hayward) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | New research to investigate links between COVID-19 and ethnicity |
Year(s) Of Engagement Activity | 2020 |
Description | UCL News-Dame Anne Johnson (2020) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | UCL scientist elected President of the Academy of Medical Sciences |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.ucl.ac.uk/news/2020/oct/ucl-scientist-elected-president-academy-medical-sciences |
Description | UCL Quantum (UCLQ) Tech Summer School |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Undergraduate students |
Results and Impact | This Summer, i-sense received hugely positive feedback from students participating in the UCL Quantum (UCLQ) Tech Summer School - an international opportunity that provides undergraduates from across the world a comprehensive introduction to the exciting field of quantum technologies. Our McKendry lab team provided demonstrations, focusing on our nanodiamond research led by Postdoctoral Research Associate, Dr Ben Miller. Undergraduates were from diverse courses including Electrical Engineering, Physics and Chemistry. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.i-sense.org.uk/news/public-engagement-annual-overview |
Description | UCL news (Hayward) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | UCL top for UK Research and Innovation funding grants |
Year(s) Of Engagement Activity | 2020 |
Description | UCL podcast: Coronavirus: The Whole Story (Anne Johnson) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | What does the black death, HIV, and Covid-19 have in common? |
Year(s) Of Engagement Activity | 2020 |
Description | UCL podcast: Coronavirus: The Whole Story (Nastouli & Hayward) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Do we understand the spread of the virus? |
Year(s) Of Engagement Activity | 2020 |
Description | UCL podcast: Coronavirus: The Whole Story (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Future earth, future tech, future health |
Year(s) Of Engagement Activity | 2020 |
Description | UCLA Seminar - Molly Stevens - Designing and translating biomaterials for therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented the seminar "Designing and translating biomaterials for therapeutics and ultrasensitive biosensing" at UCLA (USA) on the 16/Oct/2022. |
Year(s) Of Engagement Activity | 2022 |
Description | UK COVID Genomics Consortium (COG-UK) -Frampton |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | hospital-associated COVID |
Year(s) Of Engagement Activity | 2020 |
Description | University of Sussex Cornforth Lecture Jan 2024 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | The topic harnessing deep learning and quantum sensors for early disease diagnosis |
Year(s) Of Engagement Activity | 2024 |
URL | https://www.sussex.ac.uk/broadcast/read/63140 |
Description | Virtual Lecture Series on Nanodiamond, Adámas Nanotechnologies |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | The ongoing COVID-19 pandemic has emphasised the need for sensitive, early diagnosis of infectious diseases, crucial for reducing the impact of outbreaks. Nanoparticle-based rapid diagnostics, such as lateral flow tests, are widely used for antibody detection but often lack the sensitivity required for early detection of antigen or nucleic acid targets. Fluorescent labels have been investigated as a replacement for gold nanoparticles, which are widely used on lateral flow tests, but their sensitivity is limited by the background autofluorescence of the membrane or sample. This presentation discusses recently published work from our lab incorporating fluorescent nanodiamonds into lateral flow tests with the aim of improving sensitivity. In addition to their attractive properties for in vitro biosensing, including brightness and low cost, fluorescent nanodiamonds allow for selective manipulation of their emission with an external electromagnetic field. This allows their emission to be specifically modulated at a fixed frequency and separated from background autofluorescence in the frequency domain. Although significant challenges remain in translating this proof-of-concept to a field-ready diagnostic, this work demonstrates the additional sensitivity nanodiamonds could offer in numerous diagnostic test formats, assays and diseases, with the potential to improve early diagnosis of diseases, benefiting patients and populations. Miller, B.S., Bezinge, L., Gliddon, H.D. et al. Spin-enhanced nanodiamond biosensing for ultrasensitive diagnostics. Nature 587, 588-593 (2020). https://doi.org/10.1038/s41586-020-2917-1 |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.adamasnano.com/virtual-lecture-series-on-nanodiamond/ |
Description | Visit from Medicine Curator at the Science Museum |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Third sector organisations |
Results and Impact | Selina Hurley, the Medicine Curator at the Science Museum, visited the i-sense team for a laboratory tour and discussions with Prof. McKendry, Anna Byrne (Communications Manager) and PhD students about i-sense research and potential new projects/exhibits. Planned to follow up and plan a potential new exhibit with the Science Museum in 2023. |
Year(s) Of Engagement Activity | 2022 |
Description | Waleed Hassanain gave an oral presentation @ RSC Analytical research forum June 2022 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Waleed Hassanain gave the talk - SERS-based lateral flow assay for the rapid and ultra-sensitive diagnosis of bacterial infection - at the RSC Analytical research forum June 2022 organised by the Royal Society of Chemistry. Audience mainly academic and student. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.rsc.org/events/detail/48134/analytical-research-forum-2022-arf22 |
Description | Waleed Hassanain gave an oral presentation @ RSC Chemical Nanoscience and Nanotechnology Network Annual Symposium |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Waleed Hassanain gave a talk - Ultra-sensitive dual SERS/colorimetric - RPA platform for antibiotic resistance diagnostic - at the RSC Chemical Nanoscience and Nanotechnology Network Annual Symposium Jan 2023 organised by Royal Society of Chemistry |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.rsc.org/events/detail/74156/rsc-chemical-nanoscience-and-nanotechnology-network-annual-s... |
Description | Women in Stem Outreach Event |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | In July, i-sense joined with Stemettes, an award-winning social enterprise that has worked with more than 55,000 young people across the UK and Europe in 9 years. Stemettes works with girls, young women and nonbinary people aged 5 to 25 years old and supports them to make informed decisions on pursuing Science, Technology, Engineering and Maths (STEM) related careers. Alyssa Thomas Decruz, i-sense PhD student in the McKendry group, volunteered as a role model and networking panel member on the day. The event saw over 50 young girls attend and it was a fantastic opportunity to spread awareness about i-sense research to a younger age group, inspiring young girls to consider a career in infectious disease research. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.i-sense.org.uk/news/public-engagement-annual-overview |
Description | World Economic Forum (Stevens) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Biosensors and the future of diagnostics |
Year(s) Of Engagement Activity | 2020 |
Description | Wuhan University of Technology - Designing Materials for therapeutics and ultrasensitive biosensing |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Prof Molly Stevens presented a virtual guest lecture entitled "Designing Materials for therapeutics and ultrasensitive biosensing" at the Wuhan University of Technology, 28 March 2022 |
Year(s) Of Engagement Activity | 2022 |
Description | YouTube video - animation titled "How Does a Lateral Flow Work?" |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | The Stevens Group developed a YouTube animation entitled "How Does a Lateral Flow work?". The animation demonstrates how through the binding of antigens to antibodies on the test membrane, nanoparticles give a clear lateral flow test result in less than 30 minutes. The animation was widely circulated and in only a couple of months has reached almost 2,000 views on YouTube. Dr Leah Frenette is a Postdoctoral Research Associate who led on the project. She commented, "Though it felt different to a typical engagement activity, it was exciting to see the number of views climb and to know we were reaching more people than we could feasibly do face to face. It will be a great tool to be able to use in the future". Following this project's success, we look to develop further visual animations, graphics and videos to disseminate our research in the future. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.youtube.com/watch?v=pNRiLh-u9cc |
Description | eHealth revolution webinar (McKendry) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | British Embassy Switzerland |
Year(s) Of Engagement Activity | 2021 |
Description | i News (Pillay) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Scientists reject PM's claims over virus transmission |
Year(s) Of Engagement Activity | 2020 |
Description | iSense symposium |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | o Event: iSense Symposium o Date and Place: July 2023, Royal College of GPs o Type of presentation: Poster o Title: Affibodies: a promising alternative to antibodies for plate-based in vitro diagnostics |
Year(s) Of Engagement Activity | 2023 |
Description | virtual RSC conference "Materials tackling infectious disease" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Presented a talk "Rapid ultra-sensitive diagnosis of clostridium difficile infection using a SERS-based lateral flow assay " at the virtual RSC conference "Materials tackling infectious disease" The talk generated questions and discussions on the day and subsequently follow up discussions on infectious disease needs with other participants. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.rsc.org/events/detail/47905/materials-tackling-infectious-disease-a-networking-workshop |